FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ferreira, MLB
   de Albuquerque, MDPM
   de Brito, CAA
   Franca, RFD
   Moreira, AJP
   Machado, MID
   Melo, RP
   Medialdea-Carrera, R
   Mesquita, SD
   Santos, ML
   Mehta, R
   Silva, RRE
   Leonhard, SE
   Ellul, M
   Rosala-Hallas, A
   Burnside, G
   Turtle, L
   Griffiths, MJ
   Jacobs, BC
   Bhojak, M
   Willison, HJ
   Pena, LJ
   Pardo, CA
   Ximenes, RAA
   Martelli, CMT
   Brown, DWG
   Cordeiro, MT
   Lant, S
   Solomon, T
AF Brito Ferreira, Maria Lucia
   Pessoa Militao de Albuquerque, Maria de Fatima
   Antunes de Brito, Carlos Alexandre
   de Oliveira Franca, Rafael Freitas
   Porto Moreira, Alvaro Jose
   de Morais Machado, Maria Iris
   Melo, Roberta Paz
   Medialdea-Carrera, Raquel
   Mesquita, Solange Dornelas
   Santos, Marcela Lopes
   Mehta, Ravi
   Ramos e Silva, Rafael
   Leonhard, Sonja E.
   Ellul, Mark
   Rosala-Hallas, Anna
   Burnside, Girvan
   Turtle, Lance
   Griffiths, Michael J.
   Jacobs, Bart C.
   Bhojak, Maneesh
   Willison, Hugh J.
   Pena, Lindomar Jose
   Pardo, Carlos A.
   Ximenes, Ricardo A. A.
   Turchi Martelli, Celina Maria
   Brown, David W. G.
   Cordeiro, Marli Tenorio
   Lant, Suzannah
   Solomon, Tom
TI Neurological disease in adults with Zika and chikungunya virus infection
   in Northeast Brazil: a prospective observational study
SO LANCET NEUROLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CASE DEFINITIONS; ENCEPHALITIS; DIAGNOSIS;
   GUIDELINES; COLLECTION; CRITERIA; DENGUE; STATE
AB Background Since 2015, the arthropod-borne viruses (arboviruses) Zika and chikungunya have spread across the Americas causing outbreaks, accompanied by increases in immune-mediated and infectious neurological disease. The spectrum of neurological manifestations linked to these viruses, and the importance of dual infection, are not known fully. We aimed to investigate whether neurological presentations differed according to the infecting arbovirus, and whether patients with dual infection had a different disease spectrum or severity.
   Methods We report a prospective observational study done during epidemics of Zika and chikungunya viruses in Recife, Pernambuco, a dengue-endemic area of Brazil. We recruited adults aged 18 years or older referred to Hospital da Restauracao, a secondary-level and tertiary-level hospital, with suspected acute neurological disease and a history of suspected arboviral infection. We looked for evidence of Zika, chikungunya, or dengue infection by viral RNA or specific IgM antibodies in serum or CSF. We grouped patients according to their arbovirus laboratory diagnosis and then compared demographic and clinical characteristics.
   Findings Between Dec 4, 2014, and Dec 4, 2016, 1410 patients were admitted to the hospital neurology service; 201 (14%) had symptoms consistent with arbovirus infection and sufficient samples for diagnostic testing and were included in the study. The median age was 48 years (IQR 34-60), and 106 (53%) were women. 148 (74%) of 201 patients had laboratory evidence of arboviral infection. 98 (49%) of them had a single viral infection (41 [20%] had Zika, 55 [27%] had chikungunya, and two [1%] had dengue infection), whereas 50 (25%) had evidence of dual infection, mostly with Zika and chikungunya viruses (46 [23%] patients). Patients positive for arbovirus infection presented with a broad range of CNS and peripheral nervous system (PNS) disease. Chikungunya infection was more often associated with CNS disease (26 [47%] of 55 patients with chikungunya infection vs six [15%] of 41 with Zika infection; p=0.0008), especially myelitis (12 [22%] patients). Zika infection was more often associated with PNS disease (26 [63%] of 41 patients with Zika infection vs nine [16%] of 55 with chikungunya infection; p=0.0001), particularly Guillain-Barre syndrome (25 [61%] patients). Patients with Guillain-Barre syndrome who had Zika and chikungunya dual infection had more aggressive disease, requiring intensive care support and longer hospital stays, than those with mono-infection (median 24 days [IQR 20-30] vs 17 days [10-20]; p=0.0028). Eight (17%) of 46 patients with Zika and chikungunya dual infection had a stroke or transient ischaemic attack, compared with five (6%) of 96 patients with Zika or chikungunya mono-infection (p=0.047).
   Interpretation There is a wide and overlapping spectrum of neurological manifestations caused by Zika or chikungunya mono-infection and by dual infections. The possible increased risk of acute cerebrovascular disease in patients with dual infection merits further investigation.
C1 [Brito Ferreira, Maria Lucia; Porto Moreira, Alvaro Jose; de Morais Machado, Maria Iris; Melo, Roberta Paz; Mesquita, Solange Dornelas; Ramos e Silva, Rafael] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil.
   [Pessoa Militao de Albuquerque, Maria de Fatima; Santos, Marcela Lopes; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Collect Hlth, Recife, PE, Brazil.
   [de Oliveira Franca, Rafael Freitas; Pena, Lindomar Jose; Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fed Univ Pemambuco, Dept Clin Med, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Fed Univ Pemambuco, Dept Trop Med, Recife, PE, Brazil.
   [Medialdea-Carrera, Raquel; Mehta, Ravi; Ellul, Mark; Turtle, Lance; Griffiths, Michael J.; Lant, Suzannah; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England.
   [Leonhard, Sonja E.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Ellul, Mark; Bhojak, Maneesh; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Rosala-Hallas, Anna; Burnside, Girvan] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England.
   [Turtle, Lance; Solomon, Tom] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England.
   [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England.
   [Willison, Hugh J.] Univ Glasgow, Dept Neurol, Glasgow, Lanark, Scotland.
   [Willison, Hugh J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuroimmunol & Neuroinfect Disorders, Baltimore, MD 21205 USA.
   [Brown, David W. G.] Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.
   [Brown, David W. G.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Infect Dis Inst, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
RP Solomon, T (corresponding author), Univ Liverpool, Inst Infect Vet & Ecol Sci, NIHR Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
EM tsolomon@liverpool.ac.uk
FU Fundacao do Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE); EU's
   Horizon 2020 research and innovation programme; National Institute for
   Health ResearchNational Institute for Health Research (NIHR)
FX Fundacao do Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE), EU's
   Horizon 2020 research and innovation programme, National Institute for
   Health Research.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cassidy H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02677
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Hsu CH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007084
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kelly MJ, 2012, J INFECT DIS, V205, P106, DOI 10.1093/infdis/jir707
   Kirkwood B.R., 2003, ESSENTIAL MED STAT
   Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lannuzel A, 2019, NEUROLOGY, V92, pE2406, DOI 10.1212/WNL.0000000000007536
   Li HM, 2018, CAN MED ASSOC J, V190, pE285, DOI 10.1503/cmaj.170994
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Mallewa M, 2013, LANCET GLOB HEALTH, V1, pE153, DOI 10.1016/S2214-109X(13)70060-3
   McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Montecillo-Aguado MR, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7239347
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nagel MA, 2017, J NEUROIMMUNOL, V308, P112, DOI 10.1016/j.jneuroim.2017.03.014
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solomon T, 2009, BRAINS DIS NERVOUS S
   Stegmann-Planchard S, 2020, CLIN INFECT DIS, V70, P1233, DOI 10.1093/cid/ciz625
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
NR 42
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD OCT
PY 2020
VL 19
IS 10
BP 826
EP 839
PG 14
WC Clinical Neurology
SC Neurosciences & Neurology
GA OF3NN
UT WOS:000581119100020
PM 32949543
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   de Brito, MCM
   Martins, THF
   de Brito, CCM
   Albuquerque, MFM
   de Brito, RDCM
AF Brito, Carlos Alexandre Antunes de
   Brito, Marina Coelho Moraes de
   Martins, Thiago Henrique Fernandes
   Brito, Cecilia Coelho Moraes de
   Albuquerque, Maria Fatima Militao
   Brito, Rita de Cassia Coelho Moraes de
TI Clinical laboratory and dispersion pattern of COVID-19 in a family
   cluster in the social-distancing period
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE COVID-19; cluster; dispersion; social distancing
ID INTERVAL
AB Introduction: Since the first reports of coronavirus disease 2019 (COVID-19) in December 2019, the disease has spread worldwide. Different social isolation strategies have been adopted to reduce community transmission, but few studies have evaluated the pattern of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection in a family cluster during periods of isolation. We report an outbreak in 24 members of a family cluster during a period of social distancing.
   Methodology: We carried out an observational descriptive study of a family cluster infected with SARS-CoV-2 in Pernambuco, Northeast Brazil. Laboratory confirmation included RT-PCR of nasopharyngeal samples or IgM or IgG serology.
   Results: The attack rates were 75% (19/24) based on laboratory-confirmed cases and 87.5% (21/24) including probable cases. The time of spread was 17 days from the first case. All patients had mild symptoms, requiring no hospitalization, and none of them died. The frequency of symptomatic, laboratory-confirmed patients was higher among adults (94%) than among children (50%); the paediatric age group also had a higher frequency of exposed individuals who remained negative for infection. Ground-glass opacities on chest computed tomography were present in all patients with reported dyspnoea.
   Conclusion: This study highlights a high risk of intrahousehold transmission from an index case, suggesting the need for (I) specific guidelines during periods of social distancing, (II) minimization of external exposures and, above all, (III) adoption of strict quarantine measures for suspected cases and family members to prevent outbreaks from spreading.
C1 [Brito, Carlos Alexandre Antunes de] Fed Univ, Clin Hosp, Dept Internal Med, Recife, PE, Brazil.
   [Brito, Carlos Alexandre Antunes de; Brito, Marina Coelho Moraes de; Martins, Thiago Henrique Fernandes; Brito, Cecilia Coelho Moraes de; Brito, Rita de Cassia Coelho Moraes de] Autoimmune Res Inst, Recife, PE, Brazil.
   [Brito, Carlos Alexandre Antunes de; Brito, Marina Coelho Moraes de; Martins, Thiago Henrique Fernandes] Univ Fed Pernambuco, Ctr Med Sci, Recife, PE, Brazil.
   [Brito, Cecilia Coelho Moraes de; Brito, Rita de Cassia Coelho Moraes de] Inst Integral Med Fernando Figueira IMIP, Recife, PE, Brazil.
   [Albuquerque, Maria Fatima Militao] Oswaldo Cruz Fdn FIOCRUZ, Recife, PE, Brazil.
   [Brito, Rita de Cassia Coelho Moraes de] Univ Pernambuco, Fac Med Sci Pernambuco, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Internal Med, Ave Prof Moraes Rego S-N, BR-50670910 Recife, PE, Brazil.
EM cbritoc@gmail.com
OI Martins, Thiago/0000-0003-4901-6911
CR Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Bai K, 2020, PEDIATR INFECT DIS J, V39, pE100, DOI 10.1097/INF.0000000000002740
   Bohmer MM, 2020, LANCET INFECT DIS, V20, P920, DOI 10.1016/S1473-3099(20)30314-5
   Brazil. Ministry of Health, 2020, COR PAN
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen T, 2020, AM J INFECT CONTROL, V48, P1068, DOI 10.1016/j.ajic.2020.06.006
   Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092
   Dhochak N, 2020, INDIAN J PEDIATR, V87, P537, DOI 10.1007/s12098-020-03322-y
   Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251
   Ghinai I, 2020, MMWR-MORBID MORTAL W, V69, P446, DOI 10.15585/mmwr.mm6915e1
   Giwa Al, 2020, Emerg Med Pract, V22, P1
   Krishan K, 2020, J INFECT DEV COUNTR, V14, P545, DOI 10.3855/jidc.12931
   South AM, 2020, HYPERTENSION, V76, P16, DOI 10.1161/HYPERTENSIONAHA.120.15291
   Sun J, 2020, J INFECT DEV COUNTR, V14, P447, DOI 10.3855/jidc.12792
   Wang J, 2020, ADV MATER INTERFACES, V7, DOI 10.1002/admi.202000201
   WHO, 2020, CONS ADJ PUBL HLTH S
   Wolf GK, 2020, J PEDIAT INF DIS SOC, V9, P362, DOI 10.1093/jpids/piaa060
   World Health Organization, 2020, 169 WHO
   World Health Organization, 2020, 2019 NOV COR 2019 NC
   Yang MC, 2020, PUBLIC HEALTH, V185, P31, DOI 10.1016/j.puhe.2020.05.043
NR 20
TC 0
Z9 0
U1 0
U2 0
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD SEP
PY 2020
VL 14
IS 9
BP 987
EP 993
DI 10.3855/jidc.13580
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA OC1CA
UT WOS:000578899400010
PM 33031086
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   Marques, CDL
   Franca, RFO
   Monteiro, JR
   de Brito, MCM
   Lopes, F
   Lima, A
   Marques, GL
   Valadares, ML
   Duarte, ALBP
AF de Brito, Carlos A. A.
   Marques, Claudia D. L.
   Franca, Rafael F. O.
   Monteiro, Janaina R.
   de Brito, Marina C. M.
   Lopes, Fabiana
   Lima, Anton
   Marques, Gabriel L.
   Valadares, Maria Luisa
   Duarte, Angela L. B. P.
TI Reduced Duration of Postchikungunya Musculoskeletal Pain in
   Rheumatological Patients Treated with Biologicals
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID CHIKUNGUNYA VIRUS-INFECTION; ETANERCEPT; INHIBITION; ARTHRITIS;
   MORTALITY; DISEASE; ALPHA
AB Chikungunya fever (CHIK) has caused important epidemic outbreaks in the Americas, with musculoskeletal involvement being the main manifestation, causing chronic symptoms in half of the affected patients. This study was performed to evaluate the clinical course of the infection in 168 patients with autoimmune inflammatory disease using biological disease-modifying antirheumatic drugs (bDMARDs), comparing this group with 56 household controls. Anti-CHIKV IgG serology was positive in 42 (25%) of the patients in the bDMARD group and in 15 (27%) of the controls (p=0.79). Of those with positive serology, 32 (76%) and 14 (93%) were symptomatic among subjects in the bDMARD and control groups, respectively (p=0.87). Persistence of musculoskeletal symptoms for more than three months occurred in 64% of the patients in the control group and only in 28% in the bDMARD group (p=0.021), maintaining a statistically significant difference only for users of anti-TNF. This study found that patients affected by chikungunya fever using bDMARDs did not present severe forms or complications in the acute phase of the disease, and patients using anti-TNF biologicals had a lower frequency of chronic joint symptoms than the household controls. This favorable outcome may be related to the cytokine blockade, with a reduction in the inflammatory response and joint damage.
C1 [de Brito, Carlos A. A.] Univ Fed Pernambuco, Clin Hosp, Internal Med, Recife, PE, Brazil.
   [de Brito, Carlos A. A.] Autoimmune Inst, Recife, PE, Brazil.
   [Marques, Claudia D. L.; Duarte, Angela L. B. P.] Univ Fed Pernambuco, Clin Hosp, Rheumatol Serv, Recife, PE, Brazil.
   [Franca, Rafael F. O.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Virol & Expt Therapy, Recife, PE, Brazil.
   [Monteiro, Janaina R.; de Brito, Marina C. M.; Lopes, Fabiana; Lima, Anton] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques, Gabriel L.] Univ Catolica Pernambuco UNICAP, Recife, PE, Brazil.
   [Valadares, Maria Luisa] Fac Med Olinda FMO, Olinda, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Clin Hosp, Internal Med, Recife, PE, Brazil.; de Brito, CAA (corresponding author), Autoimmune Inst, Recife, PE, Brazil.
EM cbritoc@gmail.com; claudia.reumatologia@gmail.com;
   rafael.franca@cpqam.fiocruz.br; janainagrm@gmail.com;
   marina.cmbrito@gmail.com; nana.frcl@gmail.com; antonslima@gmail.com;
   gabrielm8708@gmail.com; maluvaladares@hotmail.com;
   angelalbpduarte@gmail.com
OI Coelho Moraes de Brito, Marina/0000-0002-9298-3184; Reis,
   AlessanRSS/0000-0001-8486-7469
CR de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   Assuncao-Miranda I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/973516
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Bonifay T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207406
   Borman ZA, 2018, EXPERT REV GASTROENT, V12, P1101, DOI 10.1080/17474124.2018.1530983
   Brazil Ministry of Health, 2017, MINISTRY HEALTHSECRE
   Brunier L, 2016, JOINT BONE SPINE, V83, P245, DOI 10.1016/j.jbspin.2015.08.004
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   Deligny C, 2014, J CLIN VIROL, V61, P442, DOI 10.1016/j.jcv.2014.08.011
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Marques CDL, 2017, REV BRAS REUMATOL, V57, pS421, DOI 10.1016/j.rbre.2017.05.006
   Lopez-Medrano F, 2018, CLIN MICROBIOL INFEC, V24, P192, DOI 10.1016/j.cmi.2017.06.016
   Pan American Health Organization, 2020, NEW CAS CHIK AM 2013
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Rosario V, 2015, CLIN RHEUMATOL, V34, P1285, DOI 10.1007/s10067-015-2979-x
   Rutherford AI, 2018, ANN RHEUM DIS, V77, P905, DOI 10.1136/annrheumdis-2017-212825
   Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Tanabe ISB, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00345
   Tobinick E, 2004, CURR MED RES OPIN, V20, P39, DOI 10.1185/030079903125002757
   Venugopalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111305
   Zaid A, 2011, ARTHRITIS RHEUM-US, V63, P488, DOI 10.1002/art.30112
NR 25
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PD JUL 10
PY 2020
VL 2020
AR 2071325
DI 10.1155/2020/2071325
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA MR2NK
UT WOS:000553426300001
PM 32695184
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Falcao, MB
   Cavalcanti, LPD
   Filgueiras, NM
   de Brito, CAA
AF Falcao, Melissa Barreto
   de Goes Cavalcanti, Luciano Pamplona
   Filgueiras Filho, Nivaldo Menezes
   Antunes de Brito, Carlos Alexandre
TI Case Report: Hepatotoxicity Associated with the Use of
   Hydroxychloroquine in a Patient with COVID-19
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID HEPATITIS; SECONDARY; DRUGS
AB Hydroxychloroquine (HCQ) has been used for the treatment of novel coronavirus disease (COVID-19) cases. However, evidence of efficacy remains limited, and adverse events can be associated with its use. Here, we report a case of a patient with severe COVID-19 who, after being administered HCQ, exhibited a 10-fold increase in serum levels of transaminases, followed by a rapid decrease after HCQ was withdrawn. Considering the significantly increased use of HCQduring the COVID-19 pandemic, this case alerts us to the potential for HCQ to be associated with hepatotoxicity and the need to monitor liver function during HCQ therapy.
C1 [Falcao, Melissa Barreto] Univ Estadual Feira de Santana, Res & Extens Ctr Hlth Surveillance, Feira De Santana, BA, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Filgueiras Filho, Nivaldo Menezes] Univ Salvador, Sch Med, Salvador, BA, Brazil.
   [Filgueiras Filho, Nivaldo Menezes] Univ Estado Bahia, Sch Med, Salvador, BA, Brazil.
   [Antunes de Brito, Carlos Alexandre] Clin Hosp Fed Univ, Dept Internal Med, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Trop Med Postgrad, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Autoimmune Res Inst, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Av Prof Moraes Rego S-N, BR-50670910 Recife, PE, Brazil.
EM melissa.falcao@hotmail.com; pamplona.luciano@gmail.com;
   nfilgueiras@gmail.com; cbritoc@gmail.com
CR Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   Galil SMA, 2015, LUPUS, V24, P638, DOI 10.1177/0961203314561667
   Galvan VG, 2007, CLIN RHEUMATOL, V26, P971, DOI 10.1007/s10067-006-0218-1
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Guan WJ, 2019, CLIN CHARACTERISTICS, V2020, P2020, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jamshidzadeh A., 2016, Pharmaceutical Sciences, V22, P170, DOI 10.15171/PS.2016.27
   Keshtkar-Jahromi M, 2020, AM J TROP MED HYG, V102, P932, DOI 10.4269/ajtmh.20-0230
   Liang T, 2020, HDB COVID 19 PREVENT
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1166
   MAKIN AJ, 1994, GUT, V35, P569, DOI 10.1136/gut.35.4.569
   Megarbane B, 2020, CLIN TOXICOL, DOI 10.1080/15563650.2020.1748194
   Argumanez CM, 2017, MED INTENSIVA, V41, P257, DOI 10.1016/j.medin.2016.05.004
   Mizumoto K, 2020, EMERG INFECT DIS, V26, P1
   Mok MY, 2000, CLIN EXP RHEUMATOL, V18, P363
   Niknahad H, 2016, ADV PHARM BULL, V6, P617, DOI 10.15171/apb.2016.076
   RISMANBAF A, 2020, ARCH ACAD EMERG MED, V8
   Sunkara B, 2018, LUPUS, V27, P1383, DOI 10.1177/0961203318768884
   van Jaarsveld CHM, 2000, RHEUMATOLOGY, V39, P1374, DOI 10.1093/rheumatology/39.12.1374
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wei CH, 2015, EXP MOL PATHOL, V99, P341, DOI 10.1016/j.yexmp.2015.08.006
   World Health Organization [WHO], 2020, COR DIS 2019 COVID 1
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yao X, 2020, CLIN INFECT DIS, V2, P1, DOI DOI 10.1093/CID/CIAA237
   Zhang B, 2020, CLIN CHARACTERISTICS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Zhou F, 2020, LANCET, V6736, P1, DOI DOI 10.1016/S0140-6736(20)30566-3
NR 33
TC 4
Z9 4
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2020
VL 102
IS 6
BP 1214
EP 1216
DI 10.4269/ajtmh.20-0276
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LV9SO
UT WOS:000538787600026
PM 32314698
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Cavalcanti, LPD
   Farias, LABG
   Barreto, FKD
   Siqueira, AM
   Ribeiro, GS
   Freitas, ARR
   Weaver, SC
   Kitron, U
   Brito, CAA
AF de Goes Cavalcanti, Luciano Pamplona
   Brasil Gadelha Farias, Luis Arthur
   de Almeida Barreto, Francisca Kalline
   Siqueira, Andre Machado
   Ribeiro, Guilherme Sousa
   Ribas Freitas, Andre Ricardo
   Weaver, Scott C.
   Kitron, Uriel
   Antunes Brito, Carlos Alexandre
TI Chikungunya Case Classification after the Experience with Dengue
   Classification: How Much Time Will We Lose?
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS-INFECTION; OUTBREAK; MORTALITY; EPIDEMIC; DISEASE; DEATHS; ISLAND
AB In 2013, cases of chikungunya virus (CHIKV) infection were first detected in the Caribbean. Chikungunya virus rapidly spread through Central and South America, causing explosive outbreaks in naive populations. Since its emergence in 2004, the number of case and series reports describing severe, atypical manifestations seen in chikungunya patients has increased substantially, calling into question whether clinicians and health services are failing to diagnose these atypical cases because of not only insufficient knowledge but also limitations in the case classification. Although this classification based on the duration of the musculoskeletal (acute, subacute, and chronic forms) complaints helped guide therapeutic approaches directed to these manifestations, patients presenting severe or complicated forms, which are less frequent but produce most of the fatal outcomes, were not properly addressed. In Brazil and the Caribbean, a clear temporal and spatial association between excess overall mortality and the occurrence of chikungunya epidemics has been shown, supporting the hypothesis that many of these excess deaths were a consequence of CHIKV infections. Thus, accumulated experience has highlighted that the current chikungunya case classification does not encompass the actual needs presented by certain cases with atypical features nor does it contribute to early detection and management of potentially severe cases. With continued CHIKV circulation in three continents and recent reemergence in Asia and Europe, we need a classification that is prospective and informed both by initial clinical presentation and by progression of signs and symptoms.
C1 [de Goes Cavalcanti, Luciano Pamplona; Brasil Gadelha Farias, Luis Arthur; de Almeida Barreto, Francisca Kalline] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Unichristus Univ Ctr, Fac Med, Fortaleza, Ceara, Brazil.
   [Siqueira, Andre Machado] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Ribeiro, Guilherme Sousa] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ribeiro, Guilherme Sousa] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   [Ribas Freitas, Andre Ricardo] Sao Leopoldo Mand Fac, Campinas, Brazil.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
   [Antunes Brito, Carlos Alexandre] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Rua Joao Adolfo Gurgel 133, BR-60000000 Fortaleza, Ceara, Brazil.
EM pamplona.luciano@gmail.com; luisarthurbrasilk@gmail.com;
   kallineabarreto@gmail.com; amsiqueira@gmail.com; gsribeiro@gmail.com;
   arrfreitas2010@gmail.com; sweaver@utmb.edu; ukitron@emory.edu;
   cbritoc@gmail.com
RI Freitas, Andre Ricardo Ribas/L-1969-2016; Ribeiro, Guilherme/B-6624-2008
OI Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Ribeiro,
   Guilherme/0000-0002-6798-2059
FU Network of Clinical and Applied Research into Chikungunya (REPLICK)
   through funds from the Department of Science and Technology (DECIT),
   Brazilian Ministry of Health; National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq); FUNCAP; Brazilian National Council for
   Scientific and Technological Development (CNPq/Brazil)National Council
   for Scientific and Technological Development (CNPq)
FX This work was partially supported by the Network of Clinical and Applied
   Research into Chikungunya (REPLICK) through funds from the Department of
   Science and Technology (DECIT), Brazilian Ministry of Health, the
   National Council for Scientific and Technological Development, and
   FUNCAP. G. S. R. and L. P. G. C. are recipients of the fellowship for
   research productivity granted by the Brazilian National Council for
   Scientific and Technological Development (CNPq/Brazil).
CR Akbar NA, 2012, CLIN INFECT DIS, V54, P1820, DOI 10.1093/cid/cis328
   Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P410
   de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Basuki PS, 2010, SE ASIAN J TROP MED, V41, P1088
   Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Beserra FLCN, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0232-2018
   Barreto FKD, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0329-2
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Freitas ARR, 2018, EPIDEMIOL INFECT, V146, P2059, DOI 10.1017/S0950268818002315
   Freitas ARR, 2017, PLOS CURR, V112, P650
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Godaert L, 2017, J AM GERIATR SOC, V65, P2510, DOI 10.1111/jgs.15004
   Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Pan American Health Organization, 2011, PREP RESP CHIK VIR I
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Rezza G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006919
   Freitas ARR, 2019, PATHOG GLOB HEALTH, V113, P27, DOI 10.1080/20477724.2019.1574111
   Freitas ARR, 2018, T ROY SOC TROP MED H, V112, P443, DOI 10.1093/trstmh/try072
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Tsai CY, 2013, J MICROBIOL IMMUNOL, V46, P271, DOI 10.1016/j.jmii.2012.07.005
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 32
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD FEB
PY 2020
VL 102
IS 2
BP 257
EP 259
DI 10.4269/ajtmh.19-0608
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KK6WZ
UT WOS:000512881500005
PM 31769391
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   Lima, PMA
   de Brito, MCM
   de Oliveira, DB
AF Antunes de Brito, Carlos Alexandre
   Andrade Lima, Petrus Moura
   Moraes de Brito, Marina Coelho
   de Oliveira, Daniela Barbosa
TI Second Episode of COVID-19 in Health Professionals: Report of Two Cases
SO INTERNATIONAL MEDICAL CASE REPORTS JOURNAL
LA English
DT Article
DE COVID-19; SARS-CoV-2; reinfection; antibody
AB Although primary infection has been shown to prevent reinfection of SARS-CoV2 (severe acute respiratory syndrome coronavirus 2) in animal models, gaps in the understanding of the immune response to the virus have not been adequately addressed, and some cases of possible reinfection have been reported; however, the frequency, relevance and proof of these events have yet to be determined. We report cases of two doctors who had two episodes of COVID-19 with positive RT-PCR (reverse transcriptase polymerase chain reaction) test results, raising the probability of reinfection. Case 1 was a 40-year-old male physician who presented fever and respiratory symptoms on April 10, with a positive RTPCR test for SARS-CoV-2, with complete improvement of symptoms in five days. After 44 days, the patient presented the same symptoms of the previous episode, associated with anosmia and dysgeusia. The results of a new RT-PCR test performed two days later were positive for SARS-CoV-2. Case 2 was a 44-year-old female physician who worked in a reference clinic for COVID-19 (coronavirus disease 2019) and had onset of symptoms indicative of the disease on April 30. The RT-PCR test was positive for SARS-CoV-2, with improvement of symptoms in six days. On May 24, the patient presented fever, cough, and sore throat accompanied by headache, asthenia, myalgia, and diarrhea, and in this new episode, anosmia and dysgeusia were also present. A new RT-PCR test from nasopharyngeal swabs was performed with a positive result. Our two patients described here and other patients with possible reinfection who are now being observed in clinical practice reinforce the need to expand the investigation. Then, if the risk of reinfection is confirmed, these findings will be relevant from a clinical-epidemiological perspective to define isolation strategies and develop vaccines.
C1 [Antunes de Brito, Carlos Alexandre] Fed Univ, Dept Internal Med, Ctr Med Sci, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre; Moraes de Brito, Marina Coelho; de Oliveira, Daniela Barbosa] Autoimmune Res Inst, Dept Immunol, Recife, PE, Brazil.
   [Andrade Lima, Petrus Moura] Inst Integral Med Fernando Figueira IMIP, Dept Digest Surg, Recife, PE, Brazil.
   [Moraes de Brito, Marina Coelho] Univ Fed Pernambuco, Ctr Med Sci, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Internal Med, Av Prof Moraes Rego S-N, BR-50670910 Recife, PE, Brazil.
EM cbritoc@gmail.com
CR [Anonymous], 2020, EXPRESS STAR
   Bongiovanni M, 2020, INFECT DIS-NOR, V52, P581, DOI 10.1080/23744235.2020.1769177
   Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14
   Chaturvedi Rahul, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.216
   Deng W, 2020, SCIENCE, DOI [10.1126/science.abc53432., DOI 10.1126/SCIENCE.ABC53432]
   Fu W, 2020, J MED VIROL, V92, P2298, DOI 10.1002/jmv.25968
   Health Secretariat of the State of Ceara Brazil, 2020, TECHN NOT REC CLIN P
   Ibarrondo FJ, 2020, NEW ENGL J MED, V383
   Kang H, 2020, J MED VIROL, DOI [10.1002/jmv.261146, DOI 10.1002/JMV.261146]
   Lafaie L, 2020, J AM GERIATR SOC, DOI 10.1111/jgs.16728
   Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783
   Sun JF, 2020, EMERG INFECT DIS, V26, P1834, DOI 10.3201/eid2608.201097
   Xiang F, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa4613., DOI 10.1093/CID/CIAA4613]
   Zayet S, 2020, INFECTION, DOI 10.1007/s15010-020-01442-3
NR 14
TC 0
Z9 0
U1 3
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-142X
J9 INT MED CASE REP J
JI INT. MED. CASE REP. J.
PY 2020
VL 13
BP 471
EP 475
DI 10.2147/IMCRJ.S277882
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA NW6GU
UT WOS:000575113900001
PM 33061670
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   Marques, CDL
   Falcao, MB
   da Cunha, RV
   Simon, F
   Valadares, LDD
   Luz, KG
   Melo, CFCDE
   Albuquerque, DD
   de Brito, MCM
   Duarte, ALBP
AF Antunes de Brito, Carlos Alexandre
   Lopes Marques, Claudia Diniz
   Falcao, Melissa Barreto
   da Cunha, Rivaldo Venancio
   Simon, Fabrice
   de Azevedo Valadares, Lilian David
   Luz, Kleber Giovanni
   de Albuquerque e Melo, Carlos Frederico Campelo
   Albuquerque Filho, Dalcy de Oliveira
   Moraes de Brito, Marina Coelho
   Branco Pinto Duarte, Angela Luzia
TI Update on the treatment of musculoskeletal manifestations in chikungunya
   fever: a guideline
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Chikungunya fever; Musculoskeletal pain; Arbovirus; Management
ID MANAGEMENT; INFECTION; ARTHRITIS; VIRUS
AB Since the emergence of the chikungunya virus in Brazil in 2014, more than 700,000 cases have been reported throughout the country, corresponding to one-third of all cases reported in the Americas. In addition to its high attack rates, resulting in hundreds of thousands of cases, the disease has high chronicity rates with persistent joint manifestations for more than 3 months, which can spread to more than half of the patients affected in the acute phase. Pain associated with musculoskeletal manifestations, often disabling, has an effect on patients' quality of life at different stages of the disease. Currently, the challenge faced by specialists is identifying the best therapy to be instituted for symptom relief despite the limited number of published intervention studies. In 2016, a multidisciplinary group published pharmacological treatment protocols for pain in patients with chikungunya, which was incorporated into the guidelines for clinical management of the Brazilian Ministry of Health in 2017; in that same year, a consensus was published by the Brazilian Society of Rheumatology about diagnosis and treatment. After 5 years of experience with chikungunya epidemics, in 2019, specialists involved in the protocols of the Brazilian Society of Rheumatology and Brazilian Ministry of Health prepared an update with the main objective of developing flowcharts for the therapeutic approach of musculoskeletal manifestations in adult patients to enable specialists at different levels of healthcare to spread and apply this guideline in a systematic and simplified manner.
C1 [Antunes de Brito, Carlos Alexandre; Lopes Marques, Claudia Diniz; Branco Pinto Duarte, Angela Luzia] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Falcao, Melissa Barreto] Univ Estadual Feira de Santana, Nucleo Pesquisa & Extensao Vigilancia Saude, Feira De Santana, BA, Brazil.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Simon, Fabrice] Aix Marseille Univ, Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, F-13015 Marseille, France.
   [de Azevedo Valadares, Lilian David] Hosp Getulio Vargas Pernambuco, Recife, PE, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Inst Med Trop, Natal, RN, Brazil.
   [de Albuquerque e Melo, Carlos Frederico Campelo] Unidade Tecn Doencas Transmissiveis & Analise Sit, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Albuquerque Filho, Dalcy de Oliveira] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Moraes de Brito, Marina Coelho] Univ Fed Pernambuco, Ctr Ciencias Med, Recife, PE, Brazil.
   [Lopes Marques, Claudia Diniz; Branco Pinto Duarte, Angela Luzia] Univ Fed Pernambuco, Hosp Clin, Serv Reumatol, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
EM cbritoc@gmail.com
OI Coelho Moraes de Brito, Marina/0000-0002-9298-3184
CR Amaral JK, 2018, ARTHRIT CARE RES, V70, P1501, DOI 10.1002/acr.23519
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   Blettery M, 2016, ARTHRITIS RHEUMATOL, V68, P2817, DOI 10.1002/art.39775
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, B EP, V48, P1
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao Basica, 2017, SECR AT BAS
   BRIGHTON SW, 1984, S AFR MED J, V66, P217
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Gerardin P, 2018, EMERG INFECT DIS, V24, P1773, DOI 10.3201/eid2409.180724
   Greenhalgh T, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12931
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Marques CDL, 2017, REV BRAS REUMATOL, V57, P421, DOI DOI 10.1016/J.RBR.2017.05.004
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Pan American Health Organization, 2013, NEW CAS CHIK AM, P8
   Pandya S., 2008, INDIAN J RHEUMATOL, V3, P93, DOI DOI 10.1016/S0973-3698(10)60125-2
   Ramachandran V, 2012, PLOS ONE, V7
   Ravindran V, 2017, CLIN RHEUMATOL, V36, P1335, DOI 10.1007/s10067-016-3429-0
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Rother ET, 2007, ACTA PAUL        JUN, V20, pv
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOL, V50, P1
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 29
TC 0
Z9 0
U1 1
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2020
VL 53
AR e20190517
DI 10.1590/0037-8682-0517-2019
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA MZ0PU
UT WOS:000558826500001
PM 32756797
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Botto-Menezes, CHA
   Neto, AM
   Calvet, GA
   Kara, EO
   Lacerda, MVG
   Castilho, MD
   Stroher, U
   de Brito, CAA
   Modjarrad, K
   Broutet, N
   Brasil, P
   de Filippis, AMB
   Franca, RFO
   de Abreu, AL
   Benzaken, AS
   Bermudez, XPD
   Broutet, NJN
   Giozza, SP
   Habib, N
   Landoulsi, S
   Lima, MC
   Lima, N
   de Mello, MB
   de Menezes, AIC
   Meurant, R
   Pimenta, C
   Storme, C
   Thorson, A
   Trautman, L
AF Aguiar Botto-Menezes, Camila Helena
   Neto, Armando Menezes
   Calvet, Guilherme Amaral
   Kara, Edna Oliveira
   Guimaraes Lacerda, Marcus Vinicius
   Castilho, Marcia da Costa
   Stroher, Ute
   Antunes de Brito, Carlos Alexandre
   Modjarrad, Kayvon
   Broutet, Nathalie
   Brasil, Patricia
   Bispo de Filippis, Ana Maria
   Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   Benzaken, Adele Schwartz
   Diaz Bermudez, Ximena Pamela
   Nicole Broutet, Nathalie Jeanne
   Giozza, Silvana Pereira
   Habib, Ndema
   Landoulsi, Sihem
   Lima, Morganna Costa
   Lima, Noemia
   de Mello, Maeve Brito
   Costa de Menezes, Ana Izabel
   Meurant, Robyn
   Pimenta, Cristina
   Storme, Casey
   Thorson, Anna
   Trautman, Lydie
CA ZIKABRA Study Team
TI Zika Virus in Rectal Swab Samples
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We detected Zika virus RNA in rectal swab samples from 10 patients by using real-time reverse transcription PCR, and we isolated the virus from 1 patient. The longest interval from symptom onset to detection was 14 days. These findings are applicable to diagnosis and infection prevention recommendations.
C1 [Aguiar Botto-Menezes, Camila Helena] Amazonas State Univ, Manaus, Amazonas, Brazil.
   [Aguiar Botto-Menezes, Camila Helena; Guimaraes Lacerda, Marcus Vinicius; Castilho, Marcia da Costa] Trop Med Fdn Doctor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Neto, Armando Menezes; Antunes de Brito, Carlos Alexandre; Oliveira Franca, Rafael Freitas] Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Kara, Edna Oliveira; Stroher, Ute; Broutet, Nathalie] WHO, Geneva, Switzerland.
   [Guimaraes Lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Bispo de Filippis, Ana Maria] Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
RP Franca, RFO (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Dept Virol & Expt Therapy, Av Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238; Menezes-Neto,
   Armando/0000-0002-2003-908X; Thorson, Anna/0000-0002-8703-6561
FU Wellcome TrustWellcome Trust [206522/Z/17/Z]; World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction); Brazilian
   Ministry of Health [837059/2016, 25000162039201616]; US National
   Institutes of Health National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI139777]; Henry M. Jackson Foundation
   for the Advancement of Military Medicine [W81XWH-18-2-0040]; US
   Department of the Army [W81XWH-18-2-0040]; US Defense Health Agency
   [0130602D16]; World Health Emergency Programme Organization; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI139777] Funding Source: NIH RePORTER
FX The research leading to these results received funding from Wellcome
   Trust grant no. 206522/Z/17/Z, World Health Organization
   (UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction), World Health
   Emergency Programme Organization, Brazilian Ministry of Health (Convenio
   no. 837059/2016, Processo 25000162039201616), US National Institutes of
   Health National Institute of Allergy and Infectious Diseases (award no.
   R21AI139777). This work was supported by a cooperative agreement
   (W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the
   Advancement of Military Medicine and the US Department of the Army. The
   work was funded by the US Defense Health Agency (0130602D16). The
   funders had no role in study design, data collection, analysis, decision
   to publish, or preparation of the manuscript.
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li CF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0170-6
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
NR 13
TC 4
Z9 4
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2019
VL 25
IS 5
BP 951
EP 954
DI 10.3201/eid2505.180904
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HU0TG
UT WOS:000464983500014
PM 31002058
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Brito, CAF
   de Campos, MZ
AF Felicio Brito, Carlos Alexandre
   de Campos, Marcia Zendron
TI MAKING HIGHER EDUCATION LEARNING PROCESS EASIER: THE ROLE OF ACTIVE
   LEARNING STRATEGIES
SO REVISTA IBERO-AMERICANA DE ESTUDOS EM EDUCACAO
LA Spanish
DT Article
DE Active learning; Professional training; Teaching; Health; Physical
   education
AB The objective of this study was to analyze how active learning strategies - Peer Instruction, Case-based Instruction and Conceptual Mapping - may facilitate the learning of higher education health student. The research design was characterized as a survey and an observational, cross-sectional, and descriptive study. Fifty-one physical education students, of Great ABC Region, in Sao Paulo, participated of this study. Google Classroom was designed, providing support materials for study (papers and videos on the subject related to the discipline) and a structured questionnaire containing 6 objective questions, with 5 alternatives each (a, b, c, d, e) was developed. Peer Instruction, Case-based Instruction and Conceptual Mapping were adopted as study strategies. Results were analyzed by absolute and relative frequencies (percentage) and by the calculation of the Normalized Gain (NG - Mazur, 1997). Also, the subjective responses (Narratives of the students) were used for a better understanding of the phenomena. The main result obtained after the use of Peer Instruction was a NG (%) of 83.3%. The percentage of correct answers related to the class content ranged from 5.2% to 63.2%. These results suggest that the active learning strategies developed and tested in graduation level may stand out as effective alternatives to change the actual criticized scenario of higher education, notably students' lack of motivation to learn.
C1 [Felicio Brito, Carlos Alexandre] Univ Municipal Sao Caetano do Sul USCS, Escuela Salud Educ Fis, Sao Caetano do Sul, SP, Brazil.
   [Felicio Brito, Carlos Alexandre] Univ Municipal Sao Caetano do Sul USCS, Programa Maestria Profes Innovac Ensenanza Super, Sao Caetano do Sul, SP, Brazil.
   [de Campos, Marcia Zendron] Univ Paulista UNIP, Carrera Educ Fis, Sao Paulo, SP, Brazil.
RP Brito, CAF (corresponding author), Univ Municipal Sao Caetano do Sul USCS, Escuela Salud Educ Fis, Sao Caetano do Sul, SP, Brazil.; Brito, CAF (corresponding author), Univ Municipal Sao Caetano do Sul USCS, Programa Maestria Profes Innovac Ensenanza Super, Sao Caetano do Sul, SP, Brazil.
EM carlos.brito@uscs.edu.br; mzendron@unip.br
OI ZENDRON DE CAMPOS, MARCIA/0000-0002-2782-5307
CR Aciole Giovanni Gurgel, 2016, Cad. Pesqui., V46, P1172, DOI 10.1590/198053143528
   Machado MDAS, 2007, CIENC SAUDE COLETIVA, V12, P335, DOI 10.1590/S1413-81232007000200009
   Araujo D, 2007, REV BAIANA SAUDE PUB, V31, P20
   ASSMAN Hugo, 2003, REENCANTAR EDUCACAO
   Bacich L., 2015, ENSINO HIBRIDO PERSO
   BRASIL, 2002, CART PROM SAUD
   CAMPAGNOLO Rodrigo, 2014, REV SIGNOS, V35
   CESAR Ana Maria Roux Valentini Coelho, 2005, REV ELETRONICA MACKE, V1, P1
   CHIZZOTTI A, 2006, PESQUISA QUALITATIVA
   da SILVA Marcos Valerio Santos, 2017, INTERFACE COMUNICACA
   Mazur E., 1997, PEER INSTRUCTION USE
   MENEZES Maria Arlinda deAssis, 2012, REV JUSTICA EDUCACAO, V1, P2
   MOREIRA Marco Antonio, 2012, MAPAS CONCEITUAIS AP, P41
   MULLER Maykon Gonsalves, 2017, REVISTA BRASILEIRA E, V39, DOI DOI 10.1590/1806-9126-RBEF-2017-0012
   SANTAELLA Lucia, 2004, A TEORIA GERAL DOS S
   Steinert Y, 2006, MED TEACH, V28, P497, DOI 10.1080/01421590600902976
   Thomas J.R., 2012, METODOS PESQUISA ATI
   Valente JA, 2014, EDUC REV-CURITIBA, P79, DOI 10.1590/0104-4060.38645
   Yin RK, 2015, ESTUDO CASO PLANEJAM
NR 19
TC 0
Z9 0
U1 0
U2 2
PU UNIV ESTADUAL PAULISTA-UNESP, FAC CIENCIAS LETRAS ASSIS
PI ASSIS
PA CENTRO DOCUMENTACAO & APOIO PESQUISA AV DOM ANTONIO, 2100-PQ UNIV,
   ASSIS, SP CEP-19806900, BRAZIL
SN 2446-8606
EI 1982-5587
J9 REV IBERO-AM ESTUD E
JI Rev. Ibero-Am. Estud. Educ.
PD APR-JUN
PY 2019
VL 14
IS 2
BP 371
EP 387
DI 10.21723/riaee.v14i2.11769
PG 17
WC Education & Educational Research
SC Education & Educational Research
GA HR0JP
UT WOS:000462814700004
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Souza, WV
   Braga, C
   de Araujo, TVB
   Ximenes, RAA
   Albuquerque, MDPM
   Montarroyos, UR
   Miranda, DB
   Cordeiro, MT
   Dhalia, R
   Marques, ETA
   Rodrigues, LC
   Martelli, CMT
   de Brito, CAA
   Batista, JDL
   Bezerra, LCA
   Rocha, MAW
   Carvalho, MDCG
   Silva, PFS
   Pastich, F
   Valongueiro, S
   Melo, AP
   Montarroyos, U
   Ramos, RCF
   Brandao, SP
AF Castanha, Priscila M. S.
   Souza, Wayner V.
   Braga, Cynthia
   Barreto de Araujo, Thalia Velho
   Ximenes, Ricardo A. A.
   Albuquerque, Maria de Fatima P. M.
   Montarroyos, Ulisses R.
   Miranda-Filho, Democrito B.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Marques, Ernesto T. A., Jr.
   Rodrigues, Laura C.
   Martelli, Celina M. T.
   Antunes de Brito, Carlos Alexandre
   Lyra Batista, Joanna d'Arc
   Albuquerque Bezerra, Luciana Caroline
   Wanderley Rocha, Maria Angela
   Costa Gomes Carvalho, Maria Durce
   Sobral Silva, Paula Fabiana
   Pastich, Fabiana
   Valongueiro, Sandra
   Melo, Ana Paula
   Montarroyos, Ulisses
   Ferreira Ramos, Regina Coeli
   Brandao Filho, Sinval Pinto
CA Microcephaly Epidemic Res Grp
TI Perinatal analyses of Zika- and dengue virus-specific neutralizing
   antibodies: A microcephaly case-control study in an area of high dengue
   endemicity in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LOAD
AB Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.
C1 [Castanha, Priscila M. S.; Souza, Wayner V.; Braga, Cynthia; Barreto de Araujo, Thalia Velho; Albuquerque, Maria de Fatima P. M.; Cordeiro, Marli T.; Dhalia, Rafael; Marques, Ernesto T. A., Jr.; Martelli, Celina M. T.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Ximenes, Ricardo A. A.; Montarroyos, Ulisses R.; Miranda-Filho, Democrito B.] Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
EM turchicm@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; Souza, Wayner V/H-3798-2013;
   Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020; Braga,
   Maria Cynthia/A-8204-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health, Pan American Health Organization,
   Enhancing Research Activity in Epidemic Situations; National Advisory
   Board of Scientific and Technological Development (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq])National Council for
   Scientific and Technological Development (CNPq) [306708/2014-0,
   308818/2013-0, 308590/2013-9, 308491/2013-0, 304174/2014-9,
   306222/2013-2]; European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN [734584]; CuraZika
FX This study was funded by the Brazilian Ministry of Health, Pan American
   Health Organization, Enhancing Research Activity in Epidemic Situations.
   Some of the investigators received partial support from the National
   Advisory Board of Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; scholarship
   306708/2014-0 to CMTM, 308818/2013-0 to RAAX, 308590/2013-9 to DBM-F,
   308491/2013-0 to MFPMA, 304174/2014-9 to CB, and 306222/2013-2 to WVS).
   LCR is partly funded by the European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN (grant agreement no. 734584). The
   study also received parcial support from CuraZika to ETAM. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Minister of Health, 2017, MONITORAMENTO DOS CA
   Brazilian Minister of Health, 2017, 57 BRAZ MIN HLTH
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2019, EP UPD YELL FEV 25 J
   Pan American Health Organization, 2018, EP REP BRAZ
   Pan American Health Organization, 2018, REG ZIK EP UPD AM
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   SMFM Consult Series #39, 2016, J INFECT DIS, V214, pB9
   World Health Organization, 2018, ZIK VIR SIT REP
   World Health Organization, 2018, ZIK VIR FACT SHEET
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 7
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007246
DI 10.1371/journal.pntd.0007246
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300043
PM 30856223
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Neto, JP
   Brito, CAF
AF Neto, Joao Puerro
   Felicio Brito, Carlos Alexandre
TI Functional mobility related to muscle strength in elderly women
   physically active (vol 21, pg 369, 2015)
SO REVISTA BRASILEIRA DE MEDICINA DO ESPORTE
LA English
DT Correction
CR Neto JP, 2015, REV BRAS MED ESPORTE, V21, P369, DOI 10.1590/1517-869220152105112756
NR 1
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MED ESPORTE
PI SAO PAULO SP
PA AV BRIGADEIRO LUIS ANTONIO, 278, 6 AND, SAO PAULO SP, 01318 901, BRAZIL
SN 1517-8692
EI 1806-9940
J9 REV BRAS MED ESPORTE
JI Rev. Bras. Med. Esporte
PD MAR-APR
PY 2019
VL 25
IS 2
BP 175
EP 175
DI 10.1590/1517-869220152105112756ERRATUM
PG 1
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA HS4KS
UT WOS:000463832100015
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Mehta, R
   Gerardin, P
   de Brito, CAA
   Soares, CN
   Ferreira, MLB
   Solomon, T
AF Mehta, Ravi
   Gerardin, Patrick
   Antunes de Brito, Carlos Alexandre
   Soares, Cristiane Nascimento
   Brito Ferreira, Maria Lucia
   Solomon, Tom
TI Reply to Simon et al. on "The neurological complications of chikungunya
   virus: A systematic review"
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Letter
ID DISEASE
C1 [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Nat Inst Hlth Res, Liverpool, Merseyside, England.
   [Gerardin, Patrick] Ctr Hosp Univ Reunion, INSERM CIC1410, St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ Reunion, IRD 249, INSERM U1187, UM 134 PIMIT,CNRS 9192,CYROI,CHU, Sainte Clotilde, France.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Soares, Cristiane Nascimento] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Brito Ferreira, Maria Lucia] Hosp Restauracao, Recife, PE, Brazil.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England.
RP Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England.
EM ravi.mehta@liverpool.ac.uk; tsolomon@liv.ac.uk
OI Solomon, Tom/0000-0001-7266-6547
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15096,
   G116/194] Funding Source: Medline; Department of Health
   [RP-PG-0108-10048, EME/12/205/28, IS-HPU-1112-10117] Funding Source:
   Medline
CR Duvignaud A, 2018, EPIDEMIOL INFECT, V146, P633, DOI [10.1017/S0950268818000031, 10.1017/s0950268818000031]
   Fedak KM, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0037-4
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Morris G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-205
   Simon F, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1999
NR 5
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD NOV
PY 2018
VL 28
IS 6
AR e2012
DI 10.1002/rmv.2012
PG 1
WC Virology
SC Virology
GA HA2NV
UT WOS:000450076600008
PM 30357983
DA 2020-12-01
ER

PT J
AU Gomes, RG
   de Brito, CAA
   Martinelli, VF
   dos Santos, RN
   Gomes, FOD
   Peixoto, CA
   Crispim, JO
   Diniz, GTN
   Donadi, EA
   Lucena-Silva, N
AF Gomes, Renan Garcia
   Antunes de Brito, Carlos Alexandre
   Martinelli, Valeria Ferreira
   dos Santos, Rossana Nascimento
   dos Santos Gomes, Fabiana Oliveira
   Peixoto, Christina Alves
   Crispim, Janaina Oliveira
   Nunes Diniz, George Tadeu
   Donadi, Eduardo Antonio
   Lucena-Silva, Norma
TI HLA-G is expressed in intestinal samples of ulcerative colitis and
   Crohn's disease patients and HLA-G5 expression is differentially
   correlated with TNF and IL-10 cytokine expression
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; HLA-G;
   TNF; IL-10
ID INFLAMMATORY-BOWEL-DISEASE; LEUKOCYTE ANTIGEN-G;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONONUCLEAR-CELLS PRESENT;
   PERIPHERAL-BLOOD; EPITHELIAL BARRIER; COLORECTAL-CANCER; SHLA-G;
   PROFILES; RELEASE
AB HLA-G is an immunomodulatory molecule that can be produced by epithelial cells. Considering that TNF and IL-10 participate in bowel inflammatory disorders and that both cytokines modulate HLA-G, we evaluated HLA-G, TNF and IL-10 mRNA expression by qPCR and HLA-G protein levels by immunohistochemistry in two intestinal samples exhibiting different degree of inflammation within a patient suffering from Crohn's disease (CD) or ulcerative colitis (UC). Tissue HLA-G5 (P < 0.0001), TNF (P = 0.0004) and IL-10 (P = 0.0169) mRNA expression levels were higher in intestinal areas exhibiting intense inflammation compared to areas of low inflammation, and HLA-G protein levels were not associated with degree of mucosal inflammation. In CD, the expression of TNF was correlated with IL-10 in low inflamed areas, exhibiting a TNF:IL-10 ratio = 3, but in inflamed areas the ratio increased to 9-folds. In UC, the expression of TNF was correlated to IL-10, irrespective of the inflammation grade, with little variation of the TNF:IL-10 ratio in the various inflamed areas. TNF and IL-10 expression was correlated with HLA-G5 expression in mild inflamed areas. Both CD and UC samples exhibited gene and protein expression of HLA-G; and the IILA-G5 expression is differentially correlated with TNF and IL-10 levels depending on the type of the underlying inflammatory bowel disorder.
C1 [Gomes, Renan Garcia; dos Santos, Rossana Nascimento; dos Santos Gomes, Fabiana Oliveira; Peixoto, Christina Alves; Nunes Diniz, George Tadeu; Lucena-Silva, Norma] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre; Martinelli, Valeria Ferreira] Univ Fed Pernambuco, Sch Med, Dept Internal Med, Recife, PE, Brazil.
   [Crispim, Janaina Oliveira] Fed Univ Rio Gronde do Norte, Dept Pharmacol, Natal, RN, Brazil.
   [Donadi, Eduardo Antonio] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Ribeirao Preto, Brazil.
RP Lucena-Silva, N (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Immunol, Recife, PE, Brazil.
EM norma.lucena@hotmail.com
RI Lucena-Silva, Norma/AAH-9437-2019; PEIXOTO, CHRISTINA/AAD-9608-2019
FU  [CAPES: 1423213];  [CNPq: 310364/20159]
FX We thank to the Gastroenterology Outpatient Clinics of the Hospital of
   the Federal University of Pernambuco and the Program for Technological
   Development in Tools for Health (PDTIS-FIOCRUZ). Supported by the
   following grants: CAPES: 1423213 (to R.G.G) and CNPq: 310364/20159 (to
   N.L-S).
CR Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647
   Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8
   Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6
   Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z
   Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X
   Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005
   Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001
   Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068
   Chang SN, 2017, EXPERT REV CLIN PHAR, V10, P595, DOI 10.1080/17512433.2017.1318062
   Chen CH, 2010, RHEUMATOLOGY, V49, P264, DOI 10.1093/rheumatology/kep360
   Chen JX, 2013, CLIN EXP MED, V13, P135, DOI 10.1007/s10238-012-0185-6
   de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]
   Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7
   Fainardi E, 2011, CELL MOL LIFE SCI, V68, P433, DOI 10.1007/s00018-010-0584-3
   Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015
   Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872
   Guo ZY, 2015, CELL IMMUNOL, V293, P10, DOI 10.1016/j.cellimm.2014.10.003
   Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001
   Inoue S, 1999, AM J GASTROENTEROL, V94, P2441
   Jasinski-Bergner S., 2015, ONCOIMMUNOLOGY, V4, DOI [10.1080/2162402X2015.1008805, DOI 10.1080/2162402X2015.1008805]
   Kanai T, 2003, J REPROD IMMUNOL, V60, P85, DOI 10.1016/S0165-0378(03)00096-2
   Kanai T, 2001, MOL HUM REPROD, V7, P195, DOI 10.1093/molehr/7.2.195
   Kanai T, 2001, AM J REPROD IMMUNOL, V45, P94, DOI 10.1111/j.8755-8920.2001.450205.x
   Kayama H, 2012, INT IMMUNOL, V24, P673, DOI 10.1093/intimm/dxs094
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   Leon AJ, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/580450
   Manaster I., 2012, PLOS ONE, V7, P1, DOI [10.1371/journal.pone.0033395, DOI 10.1371/JOURNAL.P0NE.0033395]
   Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007
   Matricon J, 2010, SELF NONSELF, V1, P299, DOI DOI 10.4161/SELF.1.4.13560
   Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759
   Naji A, 2014, J IMMUNOL, V192, P1536, DOI 10.4049/jimmunol.1300438
   NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428
   Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280
   Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030
   de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012
   Reimers MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-486
   Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912
   Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x
   Rizzo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00592
   Rizzo R, 2008, INFLAMM BOWEL DIS, V14, P100, DOI 10.1002/ibd.20281
   Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401
   Rosadoab S, 2008, HUM IMMUNOL, V69, P9, DOI 10.1016/j.humimm.2007.11.001
   Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003
   Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076
   Torres MI, 2006, INT IMMUNOL, V18, P713, DOI 10.1093/intimm/dxl008
   Torres MI, 2004, INT IMMUNOL, V16, P579, DOI 10.1093/intimm/dxh061
   van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100
   Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6
   Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372
   Zundler S, 2017, IMMUNOL REV, V278, P263, DOI 10.1111/imr.12544
NR 50
TC 7
Z9 9
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUN
PY 2018
VL 79
IS 6
BP 477
EP 484
DI 10.1016/j.humimm.2018.03.006
PG 8
WC Immunology
SC Immunology
GA GF4NY
UT WOS:000431940800010
PM 29588183
DA 2020-12-01
ER

PT J
AU Mehta, R
   Gerardin, P
   de Brito, CAA
   Soares, CN
   Ferreira, MLB
   Solomon, T
AF Mehta, Ravi
   Gerardin, Patrick
   Antunes de Brito, Carlos Alexandre
   Soares, Cristiane Nascimento
   Brito Ferreira, Maria Lucia
   Solomon, Tom
TI The neurological complications of chikungunya virus: A systematic review
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE acute disseminated encephalomyelitis; chikungunya; complications;
   congenital infections; encephalitis; Guillain-Barre syndrome; myelitis;
   neonatal infection; neurological; optic neuritis; retinitis; uveitis
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS; NEONATAL CHIKUNGUNYA;
   HEMORRHAGIC-FEVER; CASE DEFINITIONS; REUNION ISLAND; SINGLE-CENTER;
   INFECTION; MANIFESTATIONS; DENGUE
AB We performed a systematic review on the neurological complications of chikungunya virus. Such complications are being reported increasingly, owing primarily to the scale of recent epidemics but also to a growing understanding of the virus' neurovirulence. We performed a thorough literature search using PubMed and Scopus databases, summating the data on all published reports of neurological disease associated with chikungunya virus. We appraised the data for each major condition in adults, children, and neonates, as well as evaluating the latest evidence on disease pathogenesis and management strategies. The review provides a comprehensive summary for clinicians, public health officials, and researchers tackling the challenges associated with this important emerging pathogen.
C1 [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Gerardin, Patrick] CHU Reunion, INSERM, CIC1410, St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ Reunion, CHU, CYROI, UM PIMIT CNRS 9192 134,INSERM,U1187,IRD 249, St Pierre, Reunion, France.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Infect Dis, Recife, PE, Brazil.
   [Soares, Cristiane Nascimento] Hosp Fed Servidores Estado, Dept Neurol, Rio De Janeiro, Brazil.
   [Brito Ferreira, Maria Lucia] Hosp Restauracao, Dept Neurol, Ave Agamenon Magalhaes, Recife, PE, Brazil.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
   [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
RP Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
EM ravi.mehta@liverpool.ac.uk; tsolomon@liv.ac.uk
OI Solomon, Tom/0000-0001-7266-6547
FU European Union's Horizon research and innovation programme [734584];
   National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU); Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15096]
FX European Union's Horizon 2020 research and innovation programme,
   Grant/Award Number: 734584; National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU); Medical Research Council,
   Grant/Award Number: MC_PC_15096
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Agarwal A, 2017, J NEUROVIROL
   Akileswaran C, 2016, NEW ENGL J MED, V375, P1906, DOI 10.1056/NEJMc1611877
   Alvarado-Socarras JL, 2016, J PEDIAT INF DIS SOC, V5, pE17, DOI 10.1093/jpids/piw021
   Arragain L, 2017, J PEDIAT INF DIS SOC, V6, P324, DOI 10.1093/jpids/piw058
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Bank AM, 2016, J NEUROVIROL, V22, P125, DOI 10.1007/s13365-015-0372-9
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Benzekri R, 2016, AM J TROP MED HYG, V95, P180, DOI 10.4269/ajtmh.15-0547
   Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campos GS, 2017, PEDIAT INFECT DIS J
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Centers for Disease Control and Prevention, 2016, COUNTRIES AND TERRIT
   Cerny T, 2017, NEUROCRIT CARE
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chatterjee S N, 1965, J Indian Med Assoc, V45, P314
   Chiam CW, 2015, J GEN VIROL, V96, P3243, DOI 10.1099/jgv.0.000263
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Choudhary N, 2016, J CLIN DIAGN RES, V10, pOD19, DOI 10.7860/JCDR/2016/13095.7777
   Chung SJ, 2013, J CLIN VIROL, V57, P187, DOI 10.1016/j.jcv.2013.01.004
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Das S, 2014, J PEDIAT INF DIS-GER, V9, P37, DOI 10.3233/JPI-140414
   Das T, 2015, J GEN VIROL, V96, P294, DOI 10.1099/vir.0.071175-0
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   Dutta P, 2017, INT OPHTHALMOL
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Ernould S, 2008, ARCH PEDIATRIE, V15, P253, DOI 10.1016/j.arcped.2007.10.019
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Frohman EM, 2010, NEW ENGL J MED, V363, P564, DOI 10.1056/NEJMcp1001112
   Galatas B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004281
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Gauri L A, 2012, J Assoc Physicians India, V60, P68
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gopakumar H, 2012, J CLIN NEONATOL, V1, P155, DOI 10.4103/2249-4847.101704
   Gupta D, 2015, INDIAN J PEDIATR, V82, P1065, DOI 10.1007/s12098-015-1751-1
   Her ZS, 2015, EMBO MOL MED, V7, P24, DOI 10.15252/emmm.201404459
   Horwood PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.15
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209
   JADHAV M, 1965, INDIAN J MED RES, V53, P764
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kalita J, 2013, INFECTION, V41, P727, DOI 10.1007/s15010-013-0406-2
   Karthiga V, 2016, J PEDIATR NEUROSCI, V11, P223, DOI 10.4103/1817-1745.193369
   Kashyap RS, 2014, NEUROIMMUNOMODULAT, V21, P338, DOI 10.1159/000358240
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Krishnan M, 2012, J GLOB INFECT DIS, V4, P207, DOI 10.4103/0974-777X.103898
   Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Lin J, 2016, OCUL IMMUNOL INFLAMM, P1
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-19
   Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Mahesh G, 2009, INDIAN J OPHTHALMOL, V57, P148, DOI 10.4103/0301-4738.45508
   Maity Pranab, 2014, J Assoc Physicians India, V62, P441
   Martins HAL, 2016, J NEUROINFECT DIS, V7
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musthafa A K Mohamed, 2008, J Assoc Physicians India, V56, P473
   Nagpal K, 2017, J NEUROVIROL
   Nair AG, 2012, J OPHTHALMIC INFLAMM, V2, P39, DOI 10.1007/s12348-011-0038-6
   Nascimento LB, 2017, LANCET INFECT DIS
   Nelson J, 2014, J CLIN MICROBIOL, V52, P3459, DOI 10.1128/JCM.01288-14
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pan American Health Organisation, 2017, NEW CASES OF CHIKUNG
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Priya R, 2014, VIRUS RES, V189, P194, DOI 10.1016/j.virusres.2014.05.010
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramos R, 2017, PEDIAT INFECT DIS J
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rocha VFD, 2017, OCUL IMMUNOL INFLAMM, P1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Rose N, 2011, INT J INFECT DIS, V15, pE147, DOI 10.1016/j.ijid.2010.10.004
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Scott SSO, 2017, J NEUROVIROL
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
   Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060
   SHAH KV, 1964, INDIAN J MED RES, V52, P676
   Shaikh NJ, 2015, INDIAN J MED MICROBI, V33, P454, DOI 10.4103/0255-0857.158600
   Sharma Swati, 2016, Infect Dis Obstet Gynecol, V2016, P5046091, DOI 10.1155/2016/5046091
   Shenoy S, 2012, INDIAN PEDIATR, V49, P238
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Singh A, 2017, INDIAN PEDIATR, V54, P249, DOI 10.1007/s13312-017-1040-3
   Singh SS, 2008, EPIDEMIOL INFECT, V136, P1277, DOI 10.1017/S0950268807009739
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 2004, INFECT CENTRAL NERVO
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suryawanshi SD, 2009, INDIAN J MED RES, V129, P438
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Taraphdar D, 2015, INDIAN J MED MICROBI, V33, pS153, DOI 10.4103/0255-0857.150946
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   THIRUVENGADAM KV, 1965, INDIAN J MED RES, V53, P729
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vishwanath S, 2014, INT OPHTHALMOL, V34, P851, DOI 10.1007/s10792-013-9891-7
   Wadia R. S., 2007, Annals of the Indian Academy of Neurology, V10, P198
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Witayathawornwong P, 2012, SE ASIAN J TROP MED, V43, P62
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 143
TC 37
Z9 39
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD MAY
PY 2018
VL 28
IS 3
AR e1978
DI 10.1002/rmv.1978
PG 24
WC Virology
SC Virology
GA GF5TT
UT WOS:000432031400005
PM 29671914
OA Other Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Albuquerque, MDPM
   de Souza, WV
   Araujo, TVB
   Braga, MC
   Miranda, DD
   Ximenes, RAD
   de Melo, DA
   de Brito, CAA
   Valongueiro, S
   de Melo, APL
   Brandao, SP
   Martelli, CMT
AF Pessoa Militao de Albuquerque, Maria de Fatima
   de Souza, Wayner Vieira
   Barreto Araujo, Thalia Velho
   Braga, Maria Cynthia
   Miranda-Filho, Democrito de Barros
   de Alencar Ximenes, Ricardo Arraes
   de Melo Filho, Djalma Agripino
   Antunes de Brito, Carlos Alexandre
   Valongueiro, Sandra
   Lopes de Melo, Ana Paula
   Brandao-Filho, Sinval Pinto
   Turchi Martelli, Celina Maria
TI The microcephaly epidemic and Zika virus: building knowledge in
   epidemiology
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Zika Virus; Microcephaly; Epidemics
ID BRAZIL; INFECTION; OUTBREAK; TRANSMISSION; ASSOCIATION; ANTIBODY;
   INFANTS; CAUSAL; BRAIN; CHILD
AB In August 2015, pediatric neurologists at public hospitals in Recife, Pernambuco State, Brazil, observed an increase in the number of disproportional microcephaly cases associated with other congenital anomalies. The fact caused social commotion and mobilization of the academic community and led the Brazilian Ministry of Health to declare a national public health emergency, followed by the declaration of a Public Health Emergency of International Concern by the World Health Organization. The hypothesis for the phenomenon was congenital Zika virus (ZIKV) infection, based on spatial-temporal correlation and the clinical-epidemiological characteristics of the two epidemics. Further evidence accumulated, and within the scope of epidemiological reasoning fulfilled the criteria that gave support to the hypothesis. The plausibility of the hypothesis is based on the neurotropism of ZIKV, demonstrated in animals, affecting neural progenitors in the developing brain, and in humans, due to neurological complications in adults following infection. Isolation of viral RNA and antigens in the amniotic fluid of infected mothers and in brains of newborns and fetuses with microcephaly further demonstrated the consistency of the hypothesis. The criterion of temporality was met by identifying adverse pregnancy outcomes in a cohort of mothers with a history of rash and positive ZIKV serology. Finally, the first case-control study demonstrated a strong association between microcephaly and congenital ZIKV infection. The knowledge built with the epidemiological paradigm was supported by the scientific community, thereby establishing the consensus for a causal relationship between ZIKV and the microcephaly epidemic.
C1 [Pessoa Militao de Albuquerque, Maria de Fatima; de Souza, Wayner Vieira; Braga, Maria Cynthia; Brandao-Filho, Sinval Pinto; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Ave Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
   [Barreto Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Melo Filho, Djalma Agripino] Univ Fed Pernambuco, Nucleo Saude Publ & Desenvolvimento Social, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Dept Saude Comunitaria, Recife, PE, Brazil.
RP de Souza, WV (corresponding author), Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Ave Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
EM wayner@cpqam.fiocruz.br
RI Brandao-Filho, Sinval Pinto/AAP-4792-2020; Souza, Wayner V/H-3798-2013;
   Braga, Maria Cynthia/A-8204-2013
OI Brandao-Filho, Sinval Pinto/0000-0003-3768-2810; Braga, Maria
   Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltrame A, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.150869
   Bermudez-Tamayo C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0198-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Czeresnia D, 1998, TEORIA EPIDEMIOLOGIC, P63
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Departamento de Vigilancia das Doencas Transmissiveis Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Evans D, POSSIBLE LINK PYRIPR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fine PEM, 2013, LANCET, V381, P1249, DOI 10.1016/S0140-6736(13)60766-7
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   GIESECKE J, 2002, MODERN INFECT DIS EP
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KUHN T.S., 1998, ESTRUTURA REVOLUCOES
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Luz KG, 2015, EPIDEMIOL SERV SAUDE, V24, P785, DOI 10.5123/S1679-49742015000400021
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Melo Filho D., EPIDEMIOLOGIA SOCIAL
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude, 012015 MIN SAUD
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nelvo Romário Vieira, 2016, Sex., Salud Soc. (Rio J.), V0, P246, DOI 10.1590/1984-6487.sess.2016.24.11.r
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2017, ZIK EP UPD SIT SUMM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Porta M, 2014, DICT EPIDEMIOLOGY
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rothman K.J., MODERN EPIDEMIOLOGY
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Secretaria Executiva de Vigilancia em Saude Secretaria Estadual de Saude do Estado de Pernambuco, 4315 SEVSDGCDA
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 9
Z9 9
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 10
AR e00069018
DI 10.1590/0102-311X00069018
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GX3WF
UT WOS:000447657100001
PM 30328996
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Brito, CAA
AF Antunes de Brito, Carlos Alexandre
TI Alert: Severe cases and deaths associated with Chikungunya in Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Chikungunya; Lethality; Severe cases; Epidemiology; Review
ID REUNION ISLAND; RISK-FACTORS; DENGUE; VIRUS; INFECTION; EPIDEMIC;
   OUTBREAK; INDIA; FEVER; MORTALITY
AB Since the detection of the Chikungunya virus in America in 2013, two million cases of the disease have been notified worldwide. Severe cases and deaths related to Chikungunya have been reported in India and Reunion Island, estimated at 1 death per 1,000 inhabitants. Joint involvement in the acute and chronic phase is the main clinical manifestation associated with Chikungunya. The severity of the infection may be directly attributable to viral action or indirectly, owing to decompensation of preexisting comorbidities. In Brazil, the virus was identified in 2014, and recently, there has been a significant increase in the number of deaths caused by the Chikungunya virus infection, especially in Pernambuco. However, the numbers of fatalities are probably underreported, since for many cases, the diagnosis of Chikungunya infection may not be considered, for deaths by indirect causes. An increase in the mortality rate within months of epidemic occurrence, compared to previous years has also been reported and may be associated with Chikungunya virus infection. An in-depth investigation of reported mortality in Brazil is necessary, to measure the actual impact of the deaths, thereby, allowing the identification of possible causes. This will alert professionals about the risks, and hence, enable creation of protocols that target reducing mortality.
C1 [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Clin, Fac Med, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Med Clin, Fac Med, Recife, PE, Brazil.; de Brito, CAA (corresponding author), Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Manimunda SP, 2011, EPIDEMIOL INFECT, V139, P1410, DOI 10.1017/S0950268810002542
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Ramachandran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051519
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Secretaria de Saude. Secretaria Executiva de Vigilancia a Saude, 2016, 34SE SECR SAUD SECR
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
NR 21
TC 24
Z9 24
U1 0
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2017
VL 50
IS 5
BP 585
EP 589
DI 10.1590/0037-8682-0479-2016
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FM1JU
UT WOS:000414732300002
PM 29160503
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fernandes, AIV
   Mendes, CL
   Simoes, RH
   Silva, AEVF
   Madruga, CB
   de Brito, CAA
   Castellano, LR
   Cordeiro, MT
AF Vieira Fernandes, Ana Isabel
   Mendes, Ciro Leite
   Simoes, Raissa Holmes
   Vieira Fernandes Silva, Ana Elisa
   Madruga, Clarissa Barros
   Antunes de Brito, Carlos Alexandre
   Castellano, Lucio Roberto
   Cordeiro, Marli Tenorio
TI Cardiac tamponade in a patient with severe dengue fever
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Severe dengue; Cardiac tamponade
ID MYOCARDITIS; INFECTION
AB A 26-year-old postpartum female presented with symptoms characteristic of dengue fever on the 16th day of puerperium. On the third day of the illness, the patient presented a clinical picture consistent with shock. Tests determined primary infection with dengue virus serotype 2. Cardiac tamponade was confirmed by echocardiography. This rare manifestation is described in a patient without any associated comorbidity.
C1 [Vieira Fernandes, Ana Isabel; Simoes, Raissa Holmes; Vieira Fernandes Silva, Ana Elisa; Madruga, Clarissa Barros] Univ Fed Paraiba, Serv Doencas Infecciosas & Parasitarias, Hosp Univ Lauro Wanderley, Joao Pessoa, Paraiba, Brazil.
   [Vieira Fernandes, Ana Isabel; Castellano, Lucio Roberto] Univ Fed Paraiba, Escola Tecn Saude, Grp Estudos & Pesquisas Imunol Humana, Joao Pessoa, Paraiba, Brazil.
   [Mendes, Ciro Leite] Univ Fed Paraiba, Hosp Univ Lauro Wanderley, Unidade Terapia Intens, Joao Pessoa, Paraiba, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
RP Fernandes, AIV (corresponding author), Univ Fed Paraiba, Serv Doencas Infecciosas & Parasitarias, Hosp Univ Lauro Wanderley, Joao Pessoa, Paraiba, Brazil.; Fernandes, AIV (corresponding author), Univ Fed Paraiba, Escola Tecn Saude, Grp Estudos & Pesquisas Imunol Humana, Joao Pessoa, Paraiba, Brazil.
EM anaisabelvf@gmail.com
RI Castellano, Lucio/D-8887-2015
OI Castellano, Lucio/0000-0003-0851-5298
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [576214/2008-6]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil, grant 576214/2008-6.
CR Bendwal Suresh, 2014, J Assoc Physicians India, V62, P257
   Gupta VK, 2010, JIACM, V11, P107
   Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021
   Kumar Sunil, 2010, J Intensive Care Med, V25, P175, DOI 10.1177/0885066609358955
   Miranda CH, 2013, EUR HEART J-ACUTE CA, V2, P127, DOI 10.1177/2048872613475889
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Motla M, 2011, PREHOSP DISASTER MED, V26, P335, DOI 10.1017/S1049023X11006637
   NAGARATNAM N, 1973, BRIT HEART J, V35, P204
   Oliveira Ricardo Villar Barbosa de, 2010, Radiol Bras, V43, P401, DOI 10.1590/S0100-39842010000600013
   Pesaro Antonio Eduardo, 2007, Arq. Bras. Cardiol., V89, pe12, DOI 10.1590/S0066-782X2007001400015
   Pothapregada S, 2016, INDIAN J PEDIATR, V83, P493, DOI 10.1007/s12098-015-1942-9
   Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268
   Wiwanitkit V, 2008, ACTA CARDIOL SIN, V24, P226
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 15
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2017
VL 50
IS 5
BP 701
EP 705
DI 10.1590/0037-8682-0361-2016
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FM1JU
UT WOS:000414732300021
PM 29160522
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   Teixeira, MG
AF Antunes de Brito, Carlos Alexandre
   Teixeira, Maria Gloria
TI Increased number of deaths during a chikungunya epidemic in Pernambuco,
   Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE chikungunya; arbovirus; increased death; Pernambuco
ID DENGUE; FEVER
AB In early 2016, it was suspected that there were more deaths in Pernambuco than in previous years during an epidemic of chikungunya. This study tested whether there was an increased number of deaths and, if so, whether this increase could be related to a chikungunya epidemic. Indeed, there was an increase of 4235 deaths in 2016 compared to the average of the four previous years, and the highest differences were found during the peak period of the epidemic. It was evident that not all of these deaths could be attributed to complications of chikungunya. However, considering the temporal overlap, some of these deaths may have been caused by the aggravation of pre-existing comorbidities or complications caused directly by chikungunya virus infection.
C1 [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Teixeira, Maria Gloria] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Recife, PE, Brazil.
EM cbritoc@gmail.com
RI Teixeira, Maria Gloria/G-4808-2012
OI Teixeira, Maria Gloria/0000-0003-3318-3408
CR Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024
   Collucci C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6360
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   MS - Ministerio da Saude. DATASUS, 2016, SIST INF HOSP SUS MO
   SESPE - Secretaria de Saude do Estado de Pernambuco, 2016, INF EP 48 SE50
   Solet J. L., 2007, PLOS BIOL, V77, P727
NR 8
TC 15
Z9 16
U1 0
U2 8
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2017
VL 112
IS 9
BP 650
EP 651
DI 10.1590/0074-02760170124
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FG7HB
UT WOS:000410585100010
PM 28902292
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Meneses, JD
   Ishigami, AC
   de Mello, LM
   de Albuquerque, LL
   de Brito, CAA
   Cordeiro, MT
   Pena, LJ
AF Meneses, Jucille do Amaral
   Ishigami, Ana Catarina
   de Mello, Luisa Medeiros
   de Albuquerque, Luciano Lira
   Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
   Pena, Lindomar Jose
TI Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic:
   Evidence From 87 Confirmed Cases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome (CZS); microcephaly; diaphragm paralysis; Zika
   virus; immunoglobulin M
ID VIRUS-INFECTION; DIAPHRAGMATIC PARALYSIS; ASSOCIATION; ANTIBODY; INFANTS
AB Congenital Zika virus infection has stimulated great international concern. A prospective case series of 87 infants with laboratory- confirmed congenital Zika syndrome (CZS) at the epicenter of the Brazilian Zika epidemic in Pernambuco state is presented. Mothers were interviewed for symptoms of possible Zika virus (ZIKV) infection during pregnancy, and fetal ultrasounds were obtained. Infant cerebrospinal fluid (CSF) samples were tested for ZIKV-specific antibodies, and sera were screened for other congenital infections. Neuroimaging and ophthalmologic evaluations were also performed. Sixty-six mothers (76%) reported symptoms of ZIKV infection during gestation. Fetal ultrasounds were available from 90% of the mothers, and all demonstrated brain structural abnormalities. All of the CSF samples tested positive for ZIKV immunoglobulin M. The majority of infants (89%) were term; the mean birth weight was 2577 +/- 260 g, and the mean head circumference was 28.1 +/- 1.8 cm. Severe microcephaly, defined as head circumference 3 SD below the mean for sex and gestational age, was found in 72 (82%) infants. All infants had an abnormal neurological exam, and 18 (20.7%) had arthrogryposis. The main abnormalities detected in computed tomography scans were calcifications (99%), followed by ventricular enlargement (94%), cortical hypogyration (81%), and less commonly, cerebellar hypoplasia (52%). Unilateral diaphragm paralysis was identified in 3 infants. Maternal young age, term infant, small for gestational age, and the presence of ophthalmologic abnormalities were significantly associated with a smaller head circumference Z score. Our findings, based on laboratory-confirmed ZIKV infection, add valuable evidence for the understanding of CZS.
C1 [Meneses, Jucille do Amaral; Ishigami, Ana Catarina; de Mello, Luisa Medeiros; de Albuquerque, Luciano Lira] Prof Fernando Figueira Integral Med Inst, Div Neonatol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
EM lindomar.pena@cpqam.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FACEPE (Foundation of Science and Technology of Pernambuco
   State)
FX L. J. P. is supported by grants from CNPq and FACEPE (Foundation of
   Science and Technology of Pernambuco State).
CR Ansari MK, 2010, NEUROL INDIA, V58, P596, DOI 10.4103/0028-3886.68662
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Klein Jessica L, 2016, Cerebellum Ataxias, V3, P1, DOI 10.1186/s40673-016-0039-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pan American Health Organization/World Health Organization, 2016, ZIK SUSP CONF CAS RE
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratnayake EC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-46
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 27
TC 50
Z9 50
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2017
VL 64
IS 10
BP 1302
EP 1308
DI 10.1093/cid/cix166
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EU3EX
UT WOS:000400912500002
PM 28329257
OA Bronze
DA 2020-12-01
ER

PT J
AU Lucena-Silva, N
   Assuncao, MELSD
   Ramos, FAP
   Azevedo, F
   Lessa, R
   Cordeiro, MT
   de Brito, CAA
AF Lucena-Silva, Norma
   Sales de Melo Assuncao, Maria Elisa Lucena
   Pereira Ramos, Frederico Antonio
   Azevedo, Fernanda
   Lessa Junior, Ronaldo
   Cordeiro, Marli Tenorio
   Antunes de Brito, Carlos Alexandre
TI Encephalitis associated with inappropriate antidiuretic hormone
   secretion due to chikungunya infection in Recife, State of Pernambuco,
   Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE CHIKV; Encephalitis; Syndrome of inappropriate antidiuretic hormone
   hypersecretion
ID VIRUS; MANIFESTATIONS
AB The symptoms of chikungunya virus (CHIKV) infection include fever, headache, muscle aches, skin rash, and polyarthralgia, characterized by intense pain, edema, and temporary functional impairment. This is the first report of encephalitis caused by CHIKV infection associated with an atypical presentation of syndrome of inappropriate antidiuretic hormone secretion, evolving to cognitive impairment and apraxia of speech.
C1 [Lucena-Silva, Norma] Fundacao Oswaldo Cruz, Dept Imunol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Sales de Melo Assuncao, Maria Elisa Lucena] Univ Pernambuco, Pronto Socorro Cardiol Pernambuco, Recife, PE, Brazil.
   [Pereira Ramos, Frederico Antonio; Azevedo, Fernanda] Hosp Santa Joana, Recife, PE, Brazil.
   [Lessa Junior, Ronaldo] Univ Pernambuco, Dept Radiol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Interna, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Med Interna, Recife, PE, Brazil.
EM cbritoc@gmail.com
RI Lucena-Silva, Norma/AAH-9437-2019
CR Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Rampal M., 2007, J ASSOC PHYSICIAN I, V55, P765
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Secretaria Executiva de Vigilancia em Saude, 24SE SECR EX VIG SAU
   Shaikh NJ, 2015, INDIAN J MED MICROBI, V33, P454, DOI 10.4103/0255-0857.158600
   Taraphdar D, 2015, INDIAN J MED MICROBI, V33, pS153, DOI 10.4103/0255-0857.150946
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 12
TC 0
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2017
VL 50
IS 3
BP 417
EP 422
DI 10.1590/0037-8682-0434-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FA4LY
UT WOS:000405416000024
PM 28700066
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ferreira, MLB
   de Brito, CAA
   Moreira, AJP
   Machado, MID
   Henriques-Souza, A
   Cordeiro, MT
   Marques, ETD
   Pena, LJ
AF Brito Ferreira, Maria Lucia
   Antunes de Brito, Carlos Alexandre
   Porto Moreira, Alvaro Jose
   de Morais Machado, Maria Iris
   Henriques-Souza, Adelia
   Cordeiro, Marli Tenorio
   de Azevedo Marques, Ernesto Torres, Jr.
   Pena, Lindomar Jose
TI Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis and
   Encephalitis Associated with Zika Virus Infection in Brazil: Detection
   of Viral RNA and Isolation of Virus during Late Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; TRANSMISSION
AB Zika virus (ZIKV) emerged in Brazil in 2015, which was followed by an increase of Guillain-Barre Syndrome (GBS) cases. We report the epidemiological, clinical, and laboratory findings of the first six neurological cases associated with ZIKV in Brazil seen in a reference neurology hospital in Pernambuco, Brazil. In all cases, ZIKV was detected in serum and/or cerebrospinal fluid (CSF) samples. In this case series, four cases were defined as GBS, one as acute disseminated encephalomyelitis (ADEM) and the other as encephalitis. ZIKV was detected in all cases by RT-PCR and virus isolation was successful in two patients. The time between ZIKV acute symptoms and the development of neurological manifestations varied from 3 to 13 days and ZIKV was detected between 15 and 34 days after the initial symptoms. Our results highlight the need to include ZIKV as a differential diagnosis for neurological syndromes in countries with circulation of this arbovirus. Because the viremia in these patients appears to persist longer, direct diagnostic techniques such as RT-PCR and viral isolation should be considered even if it is after the acute phase of viral infection.
C1 [Brito Ferreira, Maria Lucia; Porto Moreira, Alvaro Jose; de Morais Machado, Maria Iris] Hosp Restorat, Dept Neurol, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Henriques-Souza, Adelia] Hosp Restauracao, Dept Pediat, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres, Jr.; Pena, Lindomar Jose] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, FIOCRUZ, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM lucabrito@uol.com.br; cbritoc@gmail.com; alvarojpm@yahoo.com.br;
   irismorais@terra.com.br; adelianeuro@gmail.com; marli.tenorio@gmail.com;
   marques@pitt.edu; lindomar.pena@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX LJP is supported by grants from FACEPE and CNPq.
CR [Anonymous], 2016, ZIK EP UPD, P1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazilian Ministry of Health, 2015, PROT AT SAUD RESP OC
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Control ECfDPa, 2014, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marli T, 2016, J INFECT DIS, V214, P1897
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, 1 DEC 2015 NEUR SYND
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 24
TC 25
Z9 26
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1405
EP 1409
DI 10.4269/ajtmh.17-0106
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300020
PM 29140242
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   von Sohsten, AKA
   Leitao, CCD
   de Brito, RDCM
   Valadares, LDD
   da Fonte, CAM
   de Mesquita, ZB
   Cunha, RV
   Luz, K
   Leao, HMC
   de Brito, CM
   Frutuoso, LCV
AF Antunes de Brito, Carlos Alexandre
   Arraes von Sohsten, Ana Karla
   de Sa Leitao, Clezio Cordeiro
   Coelho Moraes de Brito, Rita de Cssia
   de Azevedo Valadares, Lilian David
   Magnata da Fonte, Caroline Araujo
   de Mesquita, Zelina Barbosa
   Cunha, Rivaldo Venancio
   Luz, Kleber
   Carneiro Leao, Helena Maria
   de Brito, Cecilia Moraes
   Vinhal Frutuoso, Livia Carla
TI Pharmacologic management of pain in patients with Chikungunya: a
   guideline
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Chikungunya; Pain; Arthralgia; Arbovirus; Treatment
ID VIRUS-INFECTION; PERSISTENT ARTHRALGIA; REUNION ISLAND; ARTHRITIS;
   MANIFESTATIONS; CHLOROQUINE; SEVERITY; THERAPY; COHORT
AB From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.
C1 [Antunes de Brito, Carlos Alexandre; de Sa Leitao, Clezio Cordeiro] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Arraes von Sohsten, Ana Karla] Real Hosp Portugues Beneficencia Pernambuco, Inst Tratamento Dor, Recife, PE, Brazil.
   [Coelho Moraes de Brito, Rita de Cssia] Univ Pernambuco, Dept Pediat, Recife, PE, Brazil.
   [de Azevedo Valadares, Lilian David] Hosp Agamenom Magalhaes, Dept Reumatol, Recife, PE, Brazil.
   [Magnata da Fonte, Caroline Araujo] Hosp Getulio Vargas, Dept Reumatol, Recife, PE, Brazil.
   [de Mesquita, Zelina Barbosa] Inst Med Integral Prof Fernando Figueira, Dept Pediat, Recife, PE, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Infectol, Campo Grande, MS, Brazil.
   [Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Luz, Kleber] Univ Fed Rio Grande do Norte, Dept Infectol, Natal, RN, Brazil.
   [Carneiro Leao, Helena Maria] Conselho Reg Med Pernambuco, Escola SUper Eet & Bioet, Recife, PE, Brazil.
   [de Brito, Cecilia Moraes] Univ Pernambuco, Curso Grad Med, Recife, PE, Brazil.
   [Vinhal Frutuoso, Livia Carla] Minist Saude, Programa Nacl Controle Dengue, Brasilia, DF, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
EM cbritoc@gmail.com
RI Frutuoso, Livia Vinhal/AAP-2745-2020
OI Frutuoso, Livia Vinhal/0000-0001-7926-1075
CR Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005
   Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71
   Assuncao-Miranda I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/973516
   Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Ministry of Water Irrigation and Electricity, 2015, FEBR CHIK MAN CLIN, P1
   Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Organizacion Panamericana de la Salud (OPS), 2011, PREP RESP ANT EV INT, P1
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Pandya S., 2008, INDIAN J RHEUMATOL, V3, P93, DOI DOI 10.1016/S0973-3698(10)60125-2
   Ramachandran V, 2014, J POSTGRAD MED, V60, P3, DOI 10.4103/0022-3859.128795
   Rosario V, 2015, CLIN RHEUMATOL, V34, P1285, DOI 10.1007/s10067-015-2979-x
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Sousa Fátima Aparecida Emm Faleiros, 2002, Rev. Latino-Am. Enfermagem, V10, P446, DOI 10.1590/S0104-11692002000300020
   Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Waymouth HE, 2013, SEMIN ARTHRITIS RHEU, V43, P273, DOI 10.1016/j.semarthrit.2013.03.003
   World Health Organization, 2009, GLOB HLTH RISKS MORT, P1
   Yaseen HM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-249
NR 32
TC 20
Z9 21
U1 1
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2016
VL 49
IS 6
BP 668
EP 679
DI 10.1590/0037-8682-0279-2016
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EH4CU
UT WOS:000391719400002
PM 28001212
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Satue, M
   Idoipe, M
   Sanchez-Perez, A
   Liarakos, VS
   Mateo, A
   Garcia-Martin, E
   Polo, V
   Gavin, A
   Brito, C
AF Satue, Maria
   Idoipe, Miriam
   Sanchez-Perez, Antonio
   Liarakos, Vasilis S.
   Mateo, Antonio
   Garcia-Martin, Elena
   Polo, Vicente
   Gavin, Alicia
   Brito, Carlos
TI Evaluation of Early Graft Detachment After Descemet Membrane Endothelial
   Keratoplasty Using New Swept-Source Optical Coherence Tomography
SO CORNEA
LA English
DT Article
DE Descemet membrane endothelial keratoplasty; graft detachment;
   swept-source optical coherence tomography
ID AXIAL SCANS; NM; ANTERIOR; OCT
AB Purpose:To evaluate the ability of Swept-source optical coherence tomography (SS-OCT) in detecting early endothelial graft detachment after Descemet membrane endothelial keratoplasty (DMEK) and to determine the possible causes of graft detachment using 2 different protocols for anterior segment (AS) imaging.Methods:Eight eyes from 8 consecutive DMEK surgeries were evaluated. High-resolution images were captured with SS-OCT using 2 different radial protocols for AS imaging (16- and 6-mm radial protocols). Central and peripheral corneal changes were evaluated.Results:All eyes developed early graft detachment detectable with the SS-OCT. The 16-mm radial protocol scanned the cornea detecting early graft detachment in 6 out of 8 cases. The 6-mm radial protocol provided detailed images of the cornea, detecting early detachment in all cases. Stromal irregularities and small remnants only detectable using SS-OCT were the possible cause of detachment in 3 cases. One of the 8 eyes had air reinjection. The detachment in that eye was apparent by slit-lamp examination. The detachments spontaneously resolved in the other 7 eyes. AS SS-OCT evaluation was found to have added diagnostic value to biomicroscopy in 5 of these eyes (64.5%).Conclusions:AS SS-OCT is sensitive in detecting early graft detachment after DMEK. The 16-mm radial protocol of Triton SS-OCT is superior regarding quick scan of the entire cornea providing a general visualization of the DMEK graft. The 6-mm radial protocol provides detailed corneal imaging of a selected area, which is useful for evaluating structural alterations that are not detectable with larger scans and may affect the adherence of the endothelial graft.
C1 [Satue, Maria; Idoipe, Miriam; Sanchez-Perez, Antonio; Mateo, Antonio; Garcia-Martin, Elena; Polo, Vicente; Brito, Carlos] IACS, IIS Aragon, Zaragoza, Spain.
   [Satue, Maria; Idoipe, Miriam; Sanchez-Perez, Antonio; Mateo, Antonio; Garcia-Martin, Elena; Polo, Vicente; Gavin, Alicia; Brito, Carlos] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.
   [Liarakos, Vasilis S.] Naval Hosp, Dept Ophthalmol, Athens, Greece.
RP Satue, M (corresponding author), Care of Arrupe P, Consultas Externas Oftalmol, Zaragoza 50009, Spain.
EM mariasatue@gmail.com
OI Idoipe, Miriam/0000-0002-0084-6247; Gavin Sancho,
   Alicia/0000-0003-1607-6993; GARCIA-MARTIN, ELENA/0000-0001-6258-2489;
   Satue, Maria/0000-0002-1609-5994; Polo Llorens,
   Vicente/0000-0002-1402-3129
CR Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183
   Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334
   Dirisamer M, 2012, ARCH OPHTHALMOL-CHIC, V130, P280, DOI 10.1001/archophthalmol.2011.343
   Groeneveld-van Beek EA, 2013, ACTA OPHTHALMOL, V91, P145, DOI 10.1111/j.1755-3768.2012.02462.x
   Huber R, 2007, OPT LETT, V32, P2049, DOI 10.1364/OL.32.002049
   Karnowski K, 2011, BIOMED OPT EXPRESS, V2, P2709, DOI 10.1364/BOE.2.002709
   Lim H, 2006, OPT EXPRESS, V14, P5937, DOI 10.1364/OE.14.005937
   Monnereau C, 2014, JAMA OPHTHALMOL, V132, P1192, DOI 10.1001/jamaophthalmol.2014.1710
   Moutsouris K, 2011, CORNEA, V30, P1369, DOI 10.1097/ICO.0b013e31820d86bd
   Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029
   Rodriguez-Calvo-de-Mora M, 2015, OPHTHALMOLOGY, V122, P464, DOI 10.1016/j.ophtha.2014.09.004
   Satue M, 2015, Arch Soc Esp Oftalmol, V90, P356, DOI 10.1016/j.oftal.2015.01.004
   Tourtas T, 2014, JAMA OPHTHALMOL, V132, P155, DOI 10.1001/jamaophthalmol.2013.6222
   Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252
   Yeh RY, 2013, OPHTHALMOLOGY, V120, P240, DOI 10.1016/j.ophtha.2012.08.011
NR 15
TC 2
Z9 3
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-3740
EI 1536-4798
J9 CORNEA
JI Cornea
PD OCT
PY 2016
VL 35
IS 10
BP 1279
EP 1284
DI 10.1097/ICO.0000000000000925
PG 6
WC Ophthalmology
SC Ophthalmology
GA DX7OC
UT WOS:000384576600006
PM 27429087
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   Cordeiro, MT
AF Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
TI One year after the Zika virus outbreak in Brazil: from hypotheses to
   evidence
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika; Microcephaly; Neurological cases; Epidemiology; Review
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; UNITED-STATES; EPIDEMIOLOGY;
   INFECTIONS; HISTORY
AB Zika virusis an arbovirus of the Flaviviridae family with two major strains, an Asian and an African strain. The main vectors involved in the transmission of Zika virus are the Aedes aegypti and Aedes albopictus mosquitoes. Despite its identification, discovered in 1947 in the Zika forest in Uganda, only isolated and sporadic occurrences of human infection were reported within a largely asymptomatic proportion of individuals. The first reported outbreak occurred in 2007 in the Yap Island, which belongs to the Federated States of Micronesia in the Pacific Ocean, and in French Polynesia, where high attack rates occurred and the first cases of associated Guillain-Barre syndrome were reported. From November 2014 to early 2015, the Northeast states of Brazil reported the first outbreaks of Zika virus infection, with laboratory confirmation of Zika virus circulation in April 2015. In the second quarter of 2015, the association between Zika virus infection and neurological symptoms was confirmed in adults. Moreover, in October 2015 a novel suspicion was raised based on clinical and epidemiological observations: that an association between Zika virus infection and neonatal microcephaly may exist. A year after the first reports on Zika virus in Brazil, many hypotheses and much evidence on the patterns of involvement of the disease and its complications have been produced, both in this country and others; other hypotheses still need to be clarified. This review is a synthesis of a new chapter in the history of medicine; it outlines the main results produced.
C1 [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick GWA, 1952, T R SOC TROP MED HYG, V46
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   European Commission, 2014, REP CRIT RAW MAT EU, V180, P1
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053.]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Ministry of Housing Urban Poverty Alleviation Government of India, 2015, PROT AT SAUD RESP OC, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD, P1
   Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUIDELINES USE ANTIR, P1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polynesie Francaise, 2014, SURV DENG ZIK POL FR, P6
   Public Health England, 2016, GUID ZIK VIR TRAV AD, P1
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Reuters News Agency, 2016, BRAZ REP ZIK INF BLO, P6
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Secretaria de Saude de Pernambuco, 2015, CIRC FEBR ZIK VIR PE, P1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization(WHO), 2016, SIK SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 22
Z9 22
U1 0
U2 15
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 537
EP 543
DI 10.1590/0037-8682-0328-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500002
PM 27812646
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Brito, CAA
   de Brito, CC
   Oliveira, AC
   Rocha, M
   Atanasio, C
   Asfora, C
   Matos, JD
   Lima, AS
   Albuquerque, MFM
AF Antunes de Brito, Carlos Alexandre
   Moraes de Brito, Cecilia Coelho
   Oliveira, Augusto Cesar
   Rocha, Marilia
   Atanasio, Caio
   Asfora, Carolina
   Matos, Julio Dourado
   Lima, Anton Saraiva
   Militao Albuquerque, Maria Fatima
TI Zika in Pernambuco: rewriting the first outbreak
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Zika; Dengue; Outbreak; Arbovirus; Surveillance
ID VIRUS OUTBREAK; STATES
AB Introduction: A Zika virus epidemic was registered in 2015 in Northeast Brazil. In the State of Pernambuco, thousands of classical cases transpired, and in the following months, neurological disturbances in adults and microcephaly in newborns emerged as complications. After the peak of the epidemic, the official system reported only four cases of Zika virus but over 100,000 cases of dengue virus. The vigilance system was unable to retrospectively estimate cases or to issue an alert to officially notified cases with possible inconsistence concerning specific arbovirosis diagnoses. Methods: To evaluate the frequency of different arbovirosis diagnoses based on clinical-epidemiologic criteria, from January to April 2015, we conducted a hospital-based cross-sectional study retrospectively analyzing suspected cases of arbovirosis. Results: Of 1,046 total suspected cases of arbovirus, 895 (86%) were classified as probable Zika virus cases, and 151 (14%) as probable dengue virus cases. The most frequent manifestations in probable Zika virus cases were exanthema (100%), pruritus (50.7%), fever (20.4%) and arthralgia (27.7%). Conclusions: In contrast to the official data, during the peak months of the arbovirosis epidemic of 2015, most cases were compatible with Zika virus infections. Hospital-based studies, although retrospective and based on secondary data from clinical files, might provide a better estimate of the number of cases relative to currently available data, if derived from several urgent care units of representative areas of a city or state. This would partially retrospectively correct some inconsistences regarding official notifications.
C1 [Antunes de Brito, Carlos Alexandre; Rocha, Marilia; Asfora, Carolina; Lima, Anton Saraiva] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Moraes de Brito, Cecilia Coelho; Oliveira, Augusto Cesar; Atanasio, Caio] Univ Fed Pernambuco, Programa Grad Med, Recife, PE, Brazil.
   [Matos, Julio Dourado] Fac Pernambucana Saude, Programa Grad Med, Recife, PE, Brazil.
   [Militao Albuquerque, Maria Fatima] Ctr Pesquisa Aggeu Magalhaes, Dept Saude Publ, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Deng L, 2015, COMPUT INTEL NEUROSC, DOI 10.1155/2015/896072
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Center for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR, P1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Ministerio da Saude, 2016, MIN SAUD B EP, V47
   Ministerio da Saude (BR), 2005, GUIA VIGILANCIA EPID
   Ministerio do genero crianca e acao social, 2016, PROC SER AD VIG FEBR, P1
   Ministry of Housing Urban Poverty Alleviation Government of India, 2015, PROT AT SAUD RESP OC, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oregon Health Autrhority, 2016, ZIK VIR INV GUID, P1
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Pan American Health Organization (PAHO). PAHO, 2015, GUIA VIG ENF VIR ZIK, P1
   Persons TM, 2016, EMERG INFECT DIS, P1
   Polynesie Francaise, 2014, SURV DENG ZIK POL FR, P6
   Secretaria Estatual de Saude de Pernambuco, 2016, MICR EXP SES PE INV, P1
   Secretaria Estatual de Saude de Pernambuco, 2015, 2015 SECR EST SAUD P, P1
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 13
Z9 13
U1 0
U2 9
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 553
EP 558
DI 10.1590/0037-8682-0245-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500004
PM 27812648
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Neto, JP
   Raso, W
   Brito, CAF
AF Puerro Neto, Joao
   Raso, Wagner
   Felicio Brito, Carlos Alexandre
TI FUNCTIONAL MOBILITY RELATED TO MUSCLE STRENGTH IN ELDERLY WOMEN
   PHYSICALLY ACTIVE
SO REVISTA BRASILEIRA DE MEDICINA DO ESPORTE
LA Portuguese
DT Article
DE aging; postural balance; muscle contraction
ID BALANCE
AB Introduction: The changes that influence functional mobility in the elderly are many, such as posture alterations, diminution of muscular force and amplitude of movement. Objective: To determine the most appropriate parameter for functional mobility estimation, as well as the effect of muscular strength on functional mobility of elderly people. Methods: The sample was constituted by 41 healthy female individuals from 60 to 78 years old who were submitted to the Time up and go (TUG) test that assess the abilities of basic mobility in fragile elderly people (time to get up and move), Berg's balance scale (BBS), functional reach test (FRT) and one maximum repetition test (1MR). Results: The principal component analysis (PCA) revealed that only Berg's scale presented eigenvalue (self-value) higher than 1, explaining 59% of the variance. On the other hand, the muscular strength was predictor of functional mobility only when the TUG has been analyzed, suggesting that 20% of functional mobility can be explained by muscular strength (R=-0.42 [R2=0.20, beta=-0.29 +/- 0.12, P=0.023]). Conclusion: The BBS seemed to represent the most appropriate procedure for functional mobility estimation. Muscular strength was predictor of functional mobility only when TUG has been analyzed.
C1 [Puerro Neto, Joao; Raso, Wagner; Felicio Brito, Carlos Alexandre] Univ Santo Amaro, Sao Paulo, SP, Brazil.
RP Neto, JP (corresponding author), Rua Inhambu 1208,Ap 31, BR-04520014 Sao Paulo, SP, Brazil.
EM joaopuerro@me.com
CR Albino Igna Luciara Raffaeli, 2012, Rev. bras. geriatr. gerontol., V15, P17, DOI 10.1590/S1809-98232012000100003
   Aveiro MC, 2004, REV BRASILEIRA CIENC, V12, P33
   BERG K, 1989, Physiotherapy Canada, V41, P304
   Bonfim AFF, REV DIGITAL BUENOS A, V13, P125
   Carriere B., 1999, BOLA SUICA TEORIA EX
   DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192
   FARIA JC, 2003, ACTA FISIATRICA, V10, P133
   Figueiredo KMOB, 2007, REV BRAS CIN DES HUM, V9, P408
   Gazzola Juliana Maria, 2006, Rev. Bras. Otorrinolaringol., V72, P683, DOI 10.1590/S0034-72992006000500016
   Goncalves DFF, 2009, BRAZ J PHYS THER, V13, P316, DOI 10.1590/S1413-35552009005000044
   Guimaraes AV, 2010, BRAZ J MOTOR BEHAV S, V5, P58
   Maciel A., 2002, AVALIACAO MULTIDISCI
   Meneses Sarah Rubia Ferreira de, 2012, Fisioter. Pesqui., V19, P26, DOI 10.1590/S1809-29502012000100006
   Miyamoto ST, 2004, BRAZ J MED BIOL RES, V37, P1411, DOI 10.1590/S0100-879X2004000900017
   Oliveira AR, 2010, BRAZ J MOTOR BEHAV S, V5, P60
   Pedro EM, 2008, CONEXOES, V6, P174
   Pereira Marta Inez Rodrigues, 2003, Rev Bras Med Esporte, V9, P325, DOI 10.1590/S1517-86922003000500007
   PINHO L, 2004, THESIS U FEDERAL MIN
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Puerro Neto J, 2012, 11 C SUD MED DEP POR, P38
   Silverthorn AC., 2003, FISIOLOGIA HUMANA
   Whippie MA., 2001, MANUAL REABILITACAO, P29
NR 22
TC 1
Z9 1
U1 0
U2 3
PU SOC BRASILEIRA MED ESPORTE
PI SAO PAULO SP
PA AV BRIGADEIRO LUIS ANTONIO, 278, 6 AND, SAO PAULO SP, 01318 901, BRAZIL
SN 1517-8692
EI 1806-9940
J9 REV BRAS MED ESPORTE
JI Rev. Bras. Med. Esporte
PD SEP-OCT
PY 2015
VL 21
IS 5
BP 369
EP 371
DI 10.1590/1517-869220152105112756
PG 3
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA CX0SC
UT WOS:000365406000008
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Gomes, RG
   de Brito, CA
   Martinelli, V
   da Costa, LB
   Donadi, EA
   Lucena-Silva, N
AF Gomes, Renan Garcia
   de Brito, Carlos Alexandre
   Martinelli, Valeria
   da Costa, Lais Baracho
   Donadi, Eduardo Antonio
   Lucena-Silva, Norma
TI CORRELATION OF HLA-G, IL-10 AND TNF GENE EXPRESSION WITH THE DEGREE OF
   INTESTINAL LESION IN BIOPSIES OF BRAZILIAN PATIENTS WITH INFLAMMATORY
   BOWEL DISEASE
SO TISSUE ANTIGENS
LA English
DT Meeting Abstract
C1 [Gomes, Renan Garcia; Lucena-Silva, Norma] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [de Brito, Carlos Alexandre; Martinelli, Valeria] Univ Fed Pernambuco, Hosp Clin Pernambuco, Recife, PE, Brazil.
   [Donadi, Eduardo Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
EM norma.lucena@hotmail.com
RI donadi, eduardo A/H-7080-2013; Lucena-Silva, Norma/AAH-9437-2019
OI donadi, eduardo A/0000-0002-9457-9601; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD AUG
PY 2015
VL 86
IS 2
BP 78
EP 79
PG 2
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA CN2NF
UT WOS:000358257700011
DA 2020-12-01
ER

PT J
AU Alonso, DO
   Bortoleto, MCA
   Goncalves, JA
   Furtado, VV
   Brito, CAF
AF Alonso, Denise O.
   Bortoleto, Maria C. A.
   Goncalves, Jessica A.
   Furtado, Veronica V.
   Brito, Carlos A. F.
TI Heart Rate Variability At Rest, Exercise And Recovery In Stroke Patients
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Meeting Abstract
CT 60th Annual Meeting of the American-College-of-Sports-Medicine
CY MAY 28-JUN 01, 2013
CL Indianapolis, IN
SP Amer Coll Sports Med
C1 [Alonso, Denise O.; Bortoleto, Maria C. A.; Goncalves, Jessica A.; Furtado, Veronica V.; Brito, Carlos A. F.] Univ Municipal Sao Caetano do Sul, Sao Caetano do Sul, Brazil.
RI Bortoleto, Marco Antonio Coelho/H-9171-2012
OI Bortoleto, Marco Antonio Coelho/0000-0003-4455-6732
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD MAY
PY 2013
VL 45
IS 5
SU 1
MA 2326
BP 544
EP 544
PG 1
WC Sport Sciences
SC Sport Sciences
GA 300ND
UT WOS:000330469704219
DA 2020-12-01
ER

PT J
AU Figueiro, AC
   Hartz, ZMD
   de Brito, CAA
   Samico, I
   Filha, NTD
   Cazarin, G
   Braga, C
   Cesse, EAP
AF Figueiro, Ana Claudia
   de Araujo Hartz, Zulmira Maria
   Antunes de Brito, Carlos Alexandre
   Samico, Isabella
   de Siqueira Filha, Noemia Teixeira
   Cazarin, Gisele
   Braga, Cynthia
   Pessoa Cesse, Eduarda Angela
TI Death from dengue fever as a sentinel event for evaluation of quality of
   healthcare: a case study in two municipalities in Northeast Brazil, 2008
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Dengue; Health Evaluation; Delivery of Health Care; Sentinel
   Surveillance
ID HEMORRHAGIC-FEVER; MEDICAL-CARE
AB Despite the existing resources for adequate dengue patient care in the Brazilian healthcare system, the case-fatality rate for the disease is still high in the country. In order to identify factors associated with dengue-related death, this study evaluated quality of care according to the degree of implementation of specific measures, the technical and scientific quality of care, and access to health services in two municipalities (counties) in Northeast Brazil. An evaluative study of the implementation analysis type was performed, with death from dengue as the sentinel event for quality of care. To assess the degree of implementation and quality of care, the study scored the interview criteria and patient chart analysis; access was evaluated by thematic analysis. As for structure and process, the health services were found to be partially adequate (70%). No geographic or economic barriers were found to explain the occurrence of deaths. Technical and scientific quality failed to achieve adequate levels in the municipalities (46% and 30%) or in the specific services, and clinical management of dengue by the health services proved insufficient.
C1 [Figueiro, Ana Claudia; Samico, Isabella; de Siqueira Filha, Noemia Teixeira; Cazarin, Gisele] Inst Med Integral Prof Fernando Figueira, BR-51020320 Recife, PE, Brazil.
   [de Araujo Hartz, Zulmira Maria] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Braga, Cynthia; Pessoa Cesse, Eduarda Angela] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP Figueiro, AC (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Jose Trajano 170,Apto 301, BR-51020320 Recife, PE, Brazil.
EM anaclaudiafigueiro@yahoo.com.br
RI Braga, Maria Cynthia/A-8204-2013; Hartz, Zulmira/J-4596-2012; Hartz,
   Zulmira/Y-6775-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; Hartz,
   Zulmira/0000-0001-9780-9428; Hartz, Zulmira/0000-0001-9780-9428
CR Australian Institute of Health and Welfare/Australian Commission on Safety and Quality in Health Care, SENT EV AUSTR PUBL H
   Bellato R, 2008, ATENCAO BASICA INTEG, P167
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Cavalcante Maria das Graças Santos, 2006, Rev. Bras. Saude Mater. Infant., V6, P437, DOI 10.1590/S1519-38292006000400011
   Champagne F, 2009, EVALUATION CONCEPTS, P225
   Dipartimento della Qualita Direzione Generale della Programmazione Sanitaria dei Livelli di Assistenza e dei Principi Etici di Sistema Ufficio III Ministero del Lavoro della Salute e delle Politiche Sociali, LIV AS PRINC ET SIST
   DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969
   DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115
   Frenk J, 1985, Salud Publica Mex, V27, P438
   Frias Paulo G., 2002, J. Pediatr. (Rio J.), V78, P509, DOI 10.1590/S0021-75572002000600012
   Gusmao-Filho FAR, 2008, THESIS CTR PESQ AGG
   Halstead S. B., 2009, F1000 MED REP, V1, P73
   Hartz ZMD, 1996, REV SAUDE PUBL, V30, P310
   Hartz Zulmira M. de Araújo, 2004, Cad. Saúde Pública, V20, pS331, DOI 10.1590/S0102-311X2004000800026
   Kalayanarooj S, 2007, AM J TROP MED HYG, V77, P534, DOI 10.4269/ajtmh.2007.77.534
   Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262
   Lopes Rosana Machado, 2004, Cad. Saúde Pública, V20, pS283, DOI 10.1590/S0102-311X2004000800022
   Medina MG, 2006, THESIS U FEDERAL BAH
   *MIN SAUD FUND NAC, 2002, PROGR NAC CONTR DENG
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   Samico Isabella, 2005, Rev. Bras. Saude Mater. Infant., V5, P229, DOI 10.1590/S1519-38292005000200012
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2010, DENG CAS DOENC BRAS
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2007, DENG DIAGN MAN CLIN
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2009, DIR NAC PREV CONTR E
   Singhi S, 2007, J PEDIAT-BRAZIL, V83, pS22, DOI 10.1590/S0021-75572007000300004
   Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   The Joint Commission, SENT EV POL PROC 200
   Torres EM, 2006, REV PANAM SALUD PUBL, V20, P60, DOI 10.1590/S1020-49892006000700013
   Uchimura Kátia Yumi, 2002, Cad. Saúde Pública, V18, P1561, DOI 10.1590/S0102-311X2002000600009
   Vuori H., 1991, DIVULG SAUDE DEBATE, V3, P17
   World Health Organization, DENG DENG HEM FEV FA
   YIN R. K., 2005, ESTUDO CASO PLANEJAM
NR 34
TC 15
Z9 16
U1 0
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD DEC
PY 2011
VL 27
IS 12
BP 2373
EP 2385
DI 10.1590/S0102-311X2011001200009
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 873MF
UT WOS:000298886700009
PM 22218580
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU De Brito, CAK
   Siqueira, PB
   De Souza, JC
   Bolini, HMA
AF Koguishi De Brito, Carlos Alexandre
   Siqueira, Priscila Becker
   De Souza, Jane Cristina
   Andre Bolini, Helena Maria
TI IN VITRO ANTIOXIDANT CAPACITY, PHENOLIC, ASCORBIC ACID AND LYCOPENE
   CONTENT OF GUAVA (Psidium guajava L.) JUICES AND NECTARS
SO BOLETIM DO CENTRO DE PESQUISA DE PROCESSAMENTO DE ALIMENTOS
LA English
DT Article
DE ANTIOXIDANT; GUAVA; JUICE; Psidium guajava L
ID VITAMIN-C CONTENTS; CAROTENOIDS; ABTS
AB The aim of this work was to determine the antioxidant capacity in vitro of three different brands of guava nectars and juices, through free radicals scavenging methods, 1,1-diphenyl-2-picrylhydrazine (DPPH) and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS(.+)), and its correlation with the total polyphenolic content, total lycopene and ascorbic acid. Brands revealed statistical differences (p <= 0.05) in antioxidant capacity, ranging from 1.9 to 7.7 molTE/mL. Antioxidant capacity presented positive correlation for ascorbic acid content and polyphenolic compounds, being relatively low for the lycopene. Different process can influence the content of these compounds as well as interfere in their antioxidant capacity. The control of the production process is important to add value to guava products and fulfill the new tendency of the market.
C1 [Koguishi De Brito, Carlos Alexandre] Univ Estadual Campinas, UNICAMP, FEA, Dept Alimentos & Nutr, Campinas, SP, Brazil.
   [Siqueira, Priscila Becker] Univ Estadual Campinas, FEA, Dept Ciencia Alimentos, Campinas, SP, Brazil.
   [De Souza, Jane Cristina; Andre Bolini, Helena Maria] Univ Estadual Campinas, FEA, Dept Alimentos & Nutr, Campinas, SP, Brazil.
RP De Brito, CAK (corresponding author), Univ Estadual Campinas, UNICAMP, FEA, Dept Alimentos & Nutr, Campinas, SP, Brazil.
EM cako.brito@gmail.com; pribecker@gmail.com; janenutri@gmail.com;
   hellini@fea.unicamp.br
RI BOLINI, HELENA MARIA ANDRE/A-8585-2011; souza, jane/I-5779-2012; BOLINI,
   HELENA/C-1139-2012
OI BOLINI, HELENA MARIA ANDRE/0000-0001-9841-4479; souza,
   jane/0000-0002-6687-2819; BOLINI, HELENA/0000-0003-1896-2526
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We are grateful to CAPES and CNPq for financial support.
CR Arnao MB, 2001, FOOD CHEM, V73, P239, DOI 10.1016/S0308-8146(00)00324-1
   Evangelista R. M., 2006, SEGURANCA ALIMENTAR, V13, P76, DOI DOI 10.20396/SAN.V13I2.1834
   Ferreira JEM, 2008, J FOOD SCI, V73, pC589, DOI 10.1111/j.1750-3841.2008.00919.x
   FERREIRA J. E. M., 2001, THESIS U ESTADUAL CA, P85
   FORGET FL, 2000, J SCI FOOD AGR, V80, P763
   Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4
   Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b
   Kim DO, 2002, J AGR FOOD CHEM, V50, P3713, DOI 10.1021/jf020071c
   Leong LP, 2002, FOOD CHEM, V76, P69, DOI 10.1016/S0308-8146(01)00251-5
   Luximon-Ramma A, 2003, J SCI FOOD AGR, V83, P496, DOI 10.1002/jsfa.1365
   Macedo G. A., 2005, BIOQUIMICA EXPT ALIM
   Mercadante AZ, 1999, ARCH LATINOAM NUTR, V49, p52S
   PADULA M, 1986, FOOD CHEM, V20, P11, DOI 10.1016/0308-8146(86)90163-9
   PADULA M, 1983, THESIS U ESTADUAL CA
   Pandey A. K., 1998, Progressive Horticulture, V30, P73
   Pellegrini N, 2003, J NUTR, V133, P2812
   PORCU OM, 2004, THESIS U ESTADUAL CA, P135
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rodriguez-Amaya D. B., 2004, TECHNICAL MONOGRAPH, V2
   Rodriguez-Amaya DB, 1999, GUIDE CAROTENOIDS AN
   SAS Institute, 2003, SAS US GUID STAT VER
   Singleton VL, 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.1172/JCI39162
   Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003
   Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b
NR 24
TC 5
Z9 5
U1 0
U2 7
PU CENTRO PESQUISA PROCESSAMENTO ALIMENTOS
PI CURITIBA PR
PA CENTRO POLITECNICO DA UFPR. CP 19083, CURITIBA PR, 81531-990, BRAZIL
SN 0102-0323
EI 1983-9774
J9 B CTR PESQUI PROC AL
JI Bol. Cent. Pesqui. Process. Aliment.
PY 2009
VL 27
IS 2
BP 175
EP 182
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA 540NT
UT WOS:000273340600001
DA 2020-12-01
ER

PT J
AU Osawa, CC
   Ferrari, CC
   Siqueira, PB
   de Brito, CAK
   Sanvido, GB
   Botelho, AP
   Alves, LR
   Cardoso, CF
   Moais, VHF
   de Melo, LLMM
   Ribeiro, APB
   Bolini, HMA
AF Osawa, Cibele Cristina
   Ferrari, Cristhiane Caroline
   Siqueira, Priscila Becker
   Koguishi de Brito, Carlos Alexandre
   Sanvido, Gustavo Braga
   Botelho, Adriana Prais
   Alves, Leonardo Rangel
   Cardoso, Claudio Fernandes
   Ferreira Moais, Viviane Helena
   Martins Medeiros de Melo, Lauro Luis
   Badan Ribeiro, Ana Paula
   Andre Bolini, Helena Maria
TI Sensory profile evaluation of light peach tea
SO CIENCIA E TECNOLOGIA DE ALIMENTOS
LA Portuguese
DT Article
DE light tea; peach; sensory analysis; quantitative descriptive analysis;
   acceptance test
AB In this work, three different brands of light peach iced tea (A, B and C), purchased in a local market and packed in PET bottles were sensory analyzed. At first, Quantitative Descriptive Analysis (QDA) was conducted in order to obtain the sensorial profile, with eleven tasters, previously selected and trained. The product acceptance was evaluated by 33 consumers, representing the target public. The QDA results were submitted to ANOVA, Tukey's test and Principal Component Analysis (PCA). The sample A was mainly characterized by banana aroma and flavor; the sample B by artificial peach aroma and refreshment; while the sample C by sweetness and natural peach aroma. The acceptance test, analyzed by ANOVA and Tukey's test, showed a greater acceptance for the sample C. The colour of the samples was evaluated by the Cielab L*a*b* method and the sample C stood out by the red colour.
C1 [Ferrari, Cristhiane Caroline; Andre Bolini, Helena Maria] Univ Estadual Campinas, FEA, Dept Alimentos & Nutr, Lab Anal Sensorial, Campinas, SP, Brazil.
RP Ferrari, CC (corresponding author), Univ Estadual Campinas, FEA, Dept Alimentos & Nutr, Lab Anal Sensorial, Campinas, SP, Brazil.
EM criscaferrari@gmail.com; hellini@fea.unicamp.br
RI BOLINI, HELENA MARIA ANDRE/A-8585-2011; Ferrari, Cristhiane
   C/A-6363-2013; Melo, Lauro/J-5138-2015; Ribeiro, Ana Paula
   Badan/B-6440-2012
OI BOLINI, HELENA MARIA ANDRE/0000-0001-9841-4479; Ferrari, Cristhiane
   C/0000-0002-3447-5173; Melo, Lauro/0000-0001-6367-8343; 
CR *ABNT, 1993, NBR12806 ABNT
   Battochio Juliana Rosa, 2006, Food Sci. Technol (Campinas), V26, P428, DOI 10.1590/S0101-20612006000200028
   BISPO ES, 2005, CIENCIA TECNOLOGIA A, V25, P375
   Calvo C., 1997, TEMAS TECNOLOGIA ALI, VI, P261
   Cardello H. M. A. B., 1998, Ciencia e Tecnologia de Alimentos, V18, P169
   CARDELLO HMA, 2001, S LATINOAMERICANO CI, V4, P254
   Cardoso Juliana Maria Porto, 2004, Food Sci. Technol (Campinas), V24, P448, DOI 10.1590/S0101-20612004000300025
   CARDOSO JMP, 2003, C INTERNO INICIACAO, V9
   MacFie H. J., 1989, Journal of Sensory Studies, V4, P129, DOI 10.1111/j.1745-459X.1989.tb00463.x
   Meilgaard M. C., 1999, SENSORY EVALUATION T
   MORAES PCB, THESIS U ESTADUAL CA
   Moskowitz H.R., 1983, PRODUCT TESTING SENS
   Santana L. R. R., 2006, Ciencia e Tecnologia de Alimentos, V26, P619, DOI 10.1590/S0101-20612006000300021
   *SAS I, 2003, SAS US GUID STAT, V8
   Stone H. S., 1993, SENSORY EVALUATION P
   Verruma-Bernardi M. R., 2003, Ciencia e Tecnologia de Alimentos, V23, P28, DOI 10.1590/S0101-20612003000100007
   Vickers Z., 1988, Journal of Sensory Studies, V3, P1, DOI 10.1111/j.1745-459X.1988.tb00425.x
NR 17
TC 1
Z9 1
U1 0
U2 11
PU SOC BRASILEIRA CIENCIA TECNOLOGIA ALIMENTOS
PI CAMPINAS
PA AV BRASIL 2880, CAXIA POSTAL 271 CEP 13001-970, CAMPINAS, SAO PAULO
   00000, BRAZIL
SN 0101-2061
EI 1678-457X
J9 CIENCIA TECNOL ALIME
JI Ciencia Tecnol. Aliment.
PD DEC
PY 2008
VL 28
SU S
BP 102
EP 108
DI 10.1590/S0101-20612008000500017
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA 415NS
UT WOS:000263941300017
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

EF